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ABSTRACT
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Despite variability in the neurofibromatosis type 1 (NF1) cognitive phenotype, attention
and executive functioning (EF) difficulties are often described, and high rates of attentiondeficit/hyperactivity disorder (ADHD) have long been associated with NF1. Despite the known
clinical relation between NF1 and ADHD, there is a paucity of research exploring potential
factors that contribute to ADHD vulnerabilities in children and adolescents with NF1.
Furthermore, recent research suggests that impairment in EF, a construct highly associated with
ADHD, occurs in children with NF1 independent of ADHD diagnosis suggesting that the
presence of EF impairment in children with NF1 may not be uniquely associated with ADHD.
Given the complexity of EF and the relative lack of literature about factors that might contribute
to EF performance in children with NF1, further research is warranted. The current study aims to
characterize EF in children with NF1, compare EF from performance-based and functional
measures, and explore potential neuropsychological, sociodemographic, and psychosocial factors
that contribute to EF in children with NF1. Overall, results confirmed that children with NF1
demonstrate difficulty on performance and functional EF measures, and difficulties were more
evident based on functional parent report of behavior. Over one-third of children with NF1 met
diagnostic criteria for ADHD; however, children with NF1 as a group demonstrated similar EF
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profiles on performance measures, independent of ADHD diagnosis. On functional parent
reported measures of EF, children with NF1 and ADHD demonstrated significantly higher levels
of executive dysfunction compared to children with NF1 without ADHD. Relations between
performance-based working memory and general cognitive functioning were found for children
with NF1, as a group. Parent report of internalizing problems were related to parent report of
functional emotional control, shifting/cognitive flexibility, and overall behavioral regulation. As
hypothesized, parent reported sleep difficulties were related to functional EF. In addition, slower
reaction times on a working memory task were related to parent report of snoring, and parent
report of restlessness during sleep was related to functional EF. Group differences between
children with NF1 who met cut-off criteria for a sleep-related breathing disorder and those that
did not were apparent when examining parent report of functional inhibition, working memory,
and self-monitoring difficulties. Overall, results highlight the utility of a multi-method
assessment of EF and provide evidence for contributing factors of overall cognition, attention,
internalizing problems, and sleep on various aspects of EF in children and adolescents with NF1.
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Factors Contributing to Executive Functioning in Children
with Neurofibromatosis type 1
Neurofibromatosis type 1 (NF1) is a common, highly variable autosomal dominant
neurodevelopmental disorder that presents in approximately 1 in 3,500 individuals. Over half of
children with NF1 manifest specific cognitive impairments, including language problems,
learning disabilities, visual-motor impairment, and visuospatial deficits (Hyman et al., 2005). In
addition, nearly half of children with NF1 also display attention and executive functioning (EF)
impairments, and high rates of attention-deficit/hyperactivity disorder (ADHD) are associated
with NF1 (Templer et al., 2013; Koth et al., 2000). Recent research suggests EF impairment
occurs in children with NF1 independent of ADHD diagnosis (Roy et al., 2014). As such, the
presence of EF impairments in children with NF1 may not be uniquely associated with ADHD.
Despite evidence that EF impairments are prevalent in children with NF1, previous studies have
rarely utilized functional measures in conjunction with more common performance-based EF
measures. Furthermore, there is a lack of literature examining potential contributions to EF
performance in children with NF1. Examination of neuropsychological, sociodemographic, and
psychosocial factors known to contribute to EF is warranted. The aims of the current study are
threefold. First, this study aims to characterize EF performance in our sample of children with
NF1. Second, this study aims to compare and contrast EF from performance-based and
functional measures; and third, this study aims to examine potential contributing variables to EF
performance in children with NF1.
In this introduction, the current literature on EF deficits and ADHD symptomatology
often reported in children with NF1 will be examined. First, I will provide general background
information about NF1, in which I will briefly describe medical features and the common
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cognitive and behavioral characteristics of children with NF1. Second, I will review research
examining EF in children with NF1 and discuss factors that may contribute to EF impairments in
children with NF1. Third, I will provide general background information about EF, including
conceptualization, development of specific EF processes, and common assessment tools used to
examine EF. Lastly, I will provide a summary and rationale for the current study.
Genetics and Medical Presentation of NF1
Neurofibromatosis type 1 (NF1) is one of the most common autosomal dominant
neurodevelopmental disorders, with an estimated incidence of 1 in 3,500 individuals. NF1 is
caused by a mutation in a gene located on chromosome 17q11.2, which codes for neurofibromin.
Neurofibromin regulates activity of ras, a protein that promotes cell division. Due to the mutation
present in NF1, the neurofibromin protein is unable to bind to ras or regulate its activity, thus
causing the ras protein to be more active. This over activity in ras protein leads to development
of tumors over time. Therefore, NF1 is progressive and complications relating to central nervous
system dysfunction worsen over time (Friedman, 1999; North, 1998).
Despite variability in the NF1 presentation, the most common physical manifestations of
NF1 include café-au-lait skin patches, cuteaneous neurofibromas, axillary freckling, and Lisch
nodules (North, 1998). Café-au-lait skin patches are present in more than 95% of individuals
with NF1 and can be the earliest sign of NF1, often presenting before 2 years of age. NF1 is
considered a multisystem disorder with many potential medical complications, including tumors,
malformations, neuropathy, neurovascular disease, and epilepsy (Friedman, 1999). While
medical abnormalities are indeed problematic for many children with NF1, the most common
complaints from parents of children with NF1 are not medical in nature, but rather are related to
neuropsychological, behavioral, and emotional functioning.
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NF1 Neuropsychological Phenotype
General Phenotype. It has been well documented that over half of children with NF1
manifest specific cognitive impairments, including language problems, math and reading
disabilities, attention and executive function (EF) deficits, and visuospatial deficits (Hyman et
al., 2005; Mautner et al., 2002; Hyman et al., 2006). Generally, there is evidence for a slight
downward shift of the normal distribution with regards to mean IQ in individuals with NF1
relative to general populations, with their performance typically falling in the low average to
average range of functioning relative to the general population and compared to sibling contrast
groups (Cutting et al., 2000; Ferner et al., 1996; Hyman et al., 2005; Sangster et al., 2011). The
presence of intellectual disability remains relatively rare in the NF1 population; however,
reported rates (4-8%) are higher than that seen in the general population (1-2%) (North et al.,
1997; Maulik et al., 2011).
NF1 research over the past several years has focused largely on the presence of attention
and learning deficits in NF1. It has been well established that children with NF1 are at a higher
risk for learning and attention difficulties compared to unaffected siblings (Vogel et al., 2017;
Ferner et al, 1996; Cutting et al, 2000; Mautner et al, 2002; Hyman et al., 2005). Difficulties with
attention affect approximately 30-50% of children with NF1, making attention difficulties a
seemingly characteristic feature of the overall cognitive profile (Hofman et al., 1994; Hyman et
al., 2005; Koth et al., 2000). Nearly half of children with NF1 meet criteria for ADHD (Hyman
et al., 2005; Mautner et al., 2002), which is significantly higher than the 4-7% diagnosed with
ADHD in the general population (Thomas et al., 2015). Attention abilities have been
systematically examined and have been discussed in the context of delineating the common
behavioral features of NF1 and to partially account for the high rates of learning deficits (Hyman
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et al., 2006; Potvin et al., 2015). Deficits related to inattention and vigilance with sustained
attention have been reported to be more prevalent in children with NF1, as opposed to
hyperactive and impulsive symptoms (Hyman et al., 2005; Templer et al., 2013). Hyman and
colleagues (2005) found deficits in sustained attention in children with NF1, even when
controlling for intellectual functioning. Furthermore, the ADHD prevalence ratio of males to
females was observed to be equal in the NF1 population, whereas the prevalence ratio of males
to females for ADHD in the general population is 2:1-3:1 (Pastor et al., 2015). It has been
suggested that ADHD represents a prevalent neuropsychiatric phenotype of NF1 due to the
pervasive nature of inattention in individuals with NF1 (Huijbregts, 2012); however, others have
suggested the possibility of an ADHD comorbidity in NF1 (Lidzba et al., 2012).
Executive Functioning in NF1. Many children with ADHD display EF deficits. As such,
it is not unexpected that early descriptions of the NF1 cognitive phenotype literature included
anecdotal observations of EF deficits through descriptions of poor performance on visualperceptual tasks which were partially explained by impulsivity (Eliason, 1986). In one of the first
studies to examine EF performance in children and adults with NF1, Ferner and colleagues
(1996) compared the performance of individuals with and without NF1 on performance-based
measures, revealing that individuals with NF1 demonstrated more difficulty inhibiting responses
on automated performance tests compared to unaffected individuals. Deficits in working memory
and flexible set-shifting were also reported in the NF1 group, and according to Ferner (1996) and
colleagues, performance by children with NF1 resembled the performance of individuals with
frontal lobe disorders.
Since these first descriptions of EF impairments in NF1, evidence from performancebased and functional behavior measures has emerged suggesting that EF, like attention,
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represents a core deficit in NF1 (see Table 1 for review of studies). Inhibition is the most
frequently reported EF impairment in children with NF1 (Ferner et al., 1996; Rowbotham et al.,
2009; Gilboa et al., 2011; Isenberg et al., 2013; Pride et al., 2017; Casnar & Klein-Tasman,
2016; Mazzocco et al., 1995; Payne et al., 2011; Mautner et al., 2002; Plasschaert et al., 2015).
Working memory deficits are also frequently reported in children with NF1 (Casnar & KleinTasman, 2016; Champion et al., 2014; Ferner et al., 1996; Gilboa et al., 2014; Huijbregts et al.,
2010; Payne et al., 2011; Plasschaert et al., 2015; Rowbotham et al., 2009; Sangster et al., 2011;
Ulrich et al., 2010). Cognitive flexibility and shifting deficits have also been observed in children
with NF1 (Casnar & Klein-Tasman, 2016; Descheemaeker et al., 2005; Hofman et al., 1994;
Lion-Francois et al., 2017; Payne et al., 2011; Plasschaert et al., 2015; Pride et al., 2010;
Rowbotham et al., 2009; Roy et al., 2014). In addition, planning and organization deficits have
been reported in children with NF1 (Galasso et al., 2014; Gilboa et al., 2014; Hofman et al.,
1994; Hyman et al., 2005; Payne et al., 2011; Plasschaert et al., 2015; Pride et al., 2010; Roy et
al., 2010). Plasschaert and colleagues (2016) conducted a multi-method study which included an
extended battery of tests to study inhibition, cognitive flexibility, working memory, and planning
in children ages 8 -18 years with NF1. Compared to an unaffected sibling group, children with
NF1 exhibited deficits on all EF domains, even after including IQ as a covariate, suggesting
problems are not merely due to lower level of cognitive functioning. In addition, all functional
behavior ratings of EF were significantly elevated, reflecting more EF difficulties, in comparison
to the contrast group. In the first study to investigate the functional correlates of response
inhibition in children with NF1, Pride and colleagues (2017) reported that children with NF1 had
significantly less activation than age-matched controls in the pre-supplementary motor area,
inferior frontal gyrus, inferior occipital gyrus and the fusiform gyrus/posterior cerebellum, a
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network previously established as crucial to the Go-No-Go processing. It was also noted that this
abnormality was associated with faster reaction times, a reflection of impulsivity, and deficits in
sustained attention.
It has also been demonstrated that EF deficits exist in children with NF1 with and without
ADHD (Heimgärtner et al., 2019; Huijbregts et al., 2012; Lion-Francois et al., 2017; Payne et al.,
2012), suggesting that ADHD alone cannot account for the EF impairments observed. Hyman
and colleagues (2005) assessed the planning and abilities of 81 children and adolescents with
NF1 and compared performance to 49 unaffected siblings using performance-based measures.
Children with NF1 performed significantly lower on all measures of planning, and children with
comorbid ADHD generally did not perform worse than children with NF1 without ADHD.
However, when controlling for IQ, the differences in performance between children with NF1
and unaffected siblings were no longer significant. These results have been confirmed by other
researchers, such as Roy and colleagues (2010), who reported that children with and without
comorbid ADHD exhibit planning deficits above and beyond the role of cognitive functioning.
Galasso and colleagues (2014) examined performance of 18 children with NF1, 18 children with
ADHD, and 18 typically developing children on functional reports of inattention and Tower of
London (Krikorian et al., 1994) performance. Significantly elevated inattention scores were
evident on the parent-reported functional measure for the NF1 and ADHD groups. Compared to
typically developing children, children with NF1 and children with ADHD showed significant
impairment on planning and problem solving on the Tower of London. When examining
relations between report of inattention and planning and problem-solving deficits, there were no
significant relations, which indicates that the deficits in problem and planning solving was not
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related to inattention. Despite using a small sample size, this study lends further support for a
core deficit in EF for children with NF1.
In summary, the medical, cognitive, and behavioral profile of NF1, while highly variable,
is notable for significant difficulties in the areas of learning, attention, and EF. There is
increasing evidence for a core deficit in EF in children with NF1. While inhibition is the most
commonly reported EF impairment in children and adolescents with NF1, impairments in
working memory, cognitive flexibility, shifting, and planning/organization have also been
described. Evidence for significant EF impairments, independent of ADHD diagnosis, has
recently accumulated. If EF impairments cannot be accounted for by ADHD diagnosis alone,
then examination of potential contributions to EF in children with NF1 is warranted.
Contributions to Executive Functioning
Examination of the relations between clinical variables of NF1 and the degree of specific
cognitive impairments in NF1 have produced little to no explanation as to why children with
NF1 display EF impairments. Previous studies have examined factors such as gender, mode of
inheritance (familial or sporadic), the presence of macrocephaly, clinical severity, and the degree
of cognitive impairment and have found no consistent significant predictors of cognitive
dysfunction (Ferner et al., 1996; Hyman et al., 2005; North et al., 1995).
Variability in EF performance can arise due to numerous factors given the gradual
maturation of the prefrontal cortex, the area of the brain most commonly related to EF and given
the vast interconnectedness of other brain regions to the prefrontal cortex. In the typically
developing literature, important contributing factors to the cognitive and behavioral profile of a
child’s functioning are the presence of salient factors known to influence EF, such as early life
conditions, including socioeconomic status (SES), internalizing problems, attention, and sleep
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(Noble et al., 2007; Rhoades et al., 2011; Blunden et al., 2005; Wagner et al., 2015b; Craske,
2012).
It has been well studied and documented how central the role of experience plays in the
development of the brain beginning early in infancy and continuing through critical
developmental periods into young adulthood. Evidence clearly suggests that early adversity
negatively affect the development of a child’s ability to efficiently process cognitive information
and regulate behavior (Hackman & Farah, 2009; Hackman et al., 2015). Children and
adolescents with limited SES resources and those from minority populations have disadvantages
in their EF skills compared to same-aged peers from higher SES backgrounds and those from
majority populations (Finn & Rock, 1997; Noble, Farah, & McCandliss, 2006; Roy & Raver,
2014). Furthermore, studies have shown a positive relationship between SES and EF
(Mezzacappa, 2004; Noble, McCandliss, & Farah, 2007; Noble, Norman, & Farah, 2005), which
is also consistent with research demonstrating positive relations between adverse environmental
experiences and frontal lobe deficits (Hackman & Farah, 2009). Notable differences with regards
to development of working memory and inhibitory control processes have been observed (Noble
et al., 2007; Hackman & Farah, 2009). In a recent study by Berthelsen and colleagues (2017),
contributions of child and family factors in early childhood, including SES, was examined in
relation to development of EF during adolescence using longitudinal data of two cohorts of
approximately 5,000 children. Results indicated that children who already exhibited a behavioral
risk, had sleep problems, displayed emotional dysregulation and hyperactivity/impulsivity, and
whose families had lower SES, poorer maternal mental health and poorer parenting, had
significant self-regulation deficits at young ages, which were directly associated with global EF
deficits in adolescence. Overall, the culmination of factors relating to behavior in early
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childhood, paired with low SES, provides important information about the predictive utility of
these early factors to later functioning. Despite this evidence in the typically developing
literature, SES has not been systematically examined in relation to EF performance in children
and adolescents with NF1.
There is evidence in the typically developing literature that children and adolescents with
EF impairments and ADHD have high rates of internalizing problems, such as anxiety and
depression (see Wagner et al., 2015b and Craske, 2012 for review). Impairments in inhibition
(Brooks et al., 2010; Maalouf et al., 2011), working memory (Brooks et al., 2010; Klimkeith et
al., 2011), shifting (Günther et al., 2011; Micco et al., 2009), and sustained attention (Cataldo et
al., 2005; Günther et al., 2011; Micco et al., 2009) have all been described in children and
adolescents with internalizing problems. In children and adolescents with NF1, there is evidence
for increased anxiety and depressive symptoms based on caregiver report (Johnson et al., 1999;
Graf et al., 2006; Barton and North, 2007); however, results from self-report in older children
and adolescents is more mixed. In a study of children and adolescents, maternal report of
withdrawal symptoms was the only clinically significant elevation, and paternal and child selfreports did not show significant differences between participants with and without NF1 (Noll et
al., 2007). As such, continued examination of the influence of anxiety and depression symptoms
on EF performance in children and adolescents with NF1 using multiple methods and informants
is necessary.
It has long been known that sleep plays an integral role in the growth, development,
learning, and behavior of children, and is essential for the developing brain and learning process
(Dahl, 1996; Blunden et al., 2005; Cirelli & Tononi, 2008; Harvey & McGlinchey, 2015). Sleep
disorders are generally classified into difficulties falling asleep, disorders of arousal, excessive

9

daytime somnolence, sleep initiation and maintenance, sleep breathing disorders, sleep-wake
transition disorders, and sleep hyperhidrosis. Prevalence rates of childhood sleep problems in the
general population are 25-40%, with problems including difficulty maintaining sleep,
sleepwalking, night terrors, nightmares, teeth grinding, hyperhidrosis, insomnia, and insufficient
sleep (Jenni & O’Connor, 2005). Evidence suggests clear associations between children’s sleep,
learning, attention, and behavior functions across development (Gozal, 1998; Gozal & Pope,
2001; Ravid et al, 2009), and have been shown to exacerbate psychosocial and
neuropsychological functioning, such as depression, anxiety, attention, EF, academic function,
and social development (Beebe, 2011). Children presenting to clinicians with sleep disturbances
frequently score significantly lower on tests of intelligence, academic performance, and EF
compared to children without sleep disturbances (Gozal, 1998; Wolfson & Carskadon, 1998;
Bourke et al, 2011). Williams and colleagues (2017) examined the associations between sleep
and self-regulation in a longitudinal study using caregiver report data collected from infancy to
age 9. Results suggest relations between early problem behaviors and self-regulation and EF
development over time. Overall, given that a substantial proportion of children exhibit sleep
problems at some point during childhood, there is a great need to consider sleep-related factors
within the context of a child’s cognitive and behavioral functioning.
Sleep problems characterized by difficulty initiating and maintaining sleep are reported in
approximately 25-50% of children and adolescents with ADHD (Marcotte et al, 1998; Corkum et
al., 1998). Furthermore, as aforementioned, there is well established evidence that both
insufficient and poor-quality sleep results in behavioral dysregulation that affects a range of
neuropsychological functions, but especially attention and EF (Fallone et al., 2002). This
seemingly bidirectional relationship between sleep problems and ADHD has vast implications
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for the manifestation of ADHD symptomatology; however, given the complexity of this
association, it is not clear whether difficulties arising from sleep problems make existing ADHD
symptoms worse in all children, or only in a subset of children with ADHD. What is clear from
this literature is that the high rates of comorbidity between children with ADHD and sleep
problems warrants regular assessment of every child with ADHD for sleep problems, and that
children who present with both ADHD and sleep problems be systemically evaluated.
Research has also suggested that children with neurodevelopmental disorders, including
children with NF1, are at an increased risk for sleep-related problems (Johnson et al, 2007;
Marcotte et al, 1998; Licis et al, 2013). Only two studies have assessed sleep-related problems in
children with NF1, which is surprising given the clear evidence that high rates of comorbidity
between ADHD and sleep problems exist, and children with NF1, as a group, have higher rates
of ADHD. Results from previous studies of children with NF1 indicate that children with NF1
have increased sleep-related problems (Johnson et al, 2007; Licis et al, 2013). In the first study to
examine sleep in children with NF1, Johnson and colleagues (2007) examined parent report data
from 64 children, ages 3-18 years, with NF1 and concluded that sleepwalking and sleep terrors
were more prevalent in the children with NF1 compared to population norms. In addition,
significant relations between sleep problems and parent reported problem behaviors were
evident. More recently, these findings were replicated and extended in a larger sample of
children with NF1 using a contrast group. Licis and colleagues (2013) examined parent report of
sleep in 129 children with NF1 and 89 unaffected siblings between the ages of 2-17 and found
that children with NF1 had increased difficulty with initiating and maintaining sleep,
transitioning between sleep and wakefulness, arousal, and hyperhidrosis compared to unaffected
siblings. Children with NF1 were reported to have a more disruptive sleep schedule,
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characterized by reduced sleep duration, more night awakenings, and longer type to sleep onset.
It was also reported that cognitive functioning, ADHD, and stimulant medications did not affect
overall sleep scores.
Overall, while there are numerous factors that may contribute to EF performance in
children, evidence from the typically developing literature points to a strong influence of home
environment factors, such as SES to the development of EF in early childhood. Accumulating
evidence suggests that internalizing problems, including depression and anxiety, and sleep
problems also contribute to the development and performance of EF. While this has been clearly
demonstrated in the typically developing population, there is a relatively less literature
systematically examining these potential contributions to EF in children and adolescents with
NF1. To our knowledge, there have been no studies that have systematically examined SES in
relation to EF performance in children with NF1. While there is some evidence that children and
adolescents with NF1 have increased rates of anxiety and depressive symptoms, the extent to
which these symptoms contribute to ADHD and EF performance in children with NF1 is not yet
understood. In the only two studies that have examined sleep problems in children with NF1,
results indicate that children with NF1 demonstrate significantly more sleep problems when
compared to the normative mean and data from unaffected siblings; however, these sleep
problems have not been systematically examined in relations to their effect on EF in children
with NF1.
Executive Functioning
The construct of EF has yet to be conceptualized using a single, widely accepted model,
but rather, is the term used for the diverse set of cognitive processes that underlie goal-directed
behavior (Miyake et al., 2000). The construct of EF has evolved over time into an umbrella term
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encapsulating at least 30 different definitions. The current dominant theory of EF comes from
Miyake and colleagues (2000), who utilized a latent variable approach to methodically examine
overlap in task performance between related EF tasks of EF; and two major themes emerged.
First, EF involves higher-order, complex cognitive processes; and second, EF involves a
“central-executive” component (Miyake et al., 2000). The complex cognitive processes
described in this theory include the ability to plan, problem solve, inhibit inappropriate responses
through self-regulation, flexibly shift mental set, and effectively organize goal-directed behavior
in both short-term and long-term timeframes. In addition, the theory notes that attention and
memory processes that guide these cognitive processes, such as working memory, selective
attention, and sustained attention, should also be incorporated within the definition of EF.
Therefore, foundational cognitive processes include inhibition, working memory, and shifting,
with closely related processes including planning, divided attention, self-monitoring, selfregulation, and initiation (Stuss & Alexander; Miyake et al., 2000; Best & Miller, 2010).
EF is strongly associated with the prefrontal cortex, which has been illustrated in studies
describing patients with prefrontal cortex damage who display EF deficits, yet have average
cognitive functioning (e.g. Stuss & Benson, 1984), and has been extensively studied (Goldstein
et al., 2013; Brocki & Bohlin, 2004; Casey et al., 2000; Tranel et al., 1994; Welsh, Pennington &
Groisser, 1991). However, given the extensive inter-connectivity of the prefrontal cortex with
other regions of the brain, including the basal ganglia, anterior cingulate gyrus, cerebellum, and
thalamus (Baddeley & Della Sala, 1998), EF is highly susceptible to disruptions in multiple brain
regions that lead to significant variability in functioning.

Development of Executive Functioning
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In typically developing children, EF abilities emerge and develop rapidly during the first
year of life, and continue developing gradually in stages (Diamond, 1991). The processes related
to EF within this first year of life include recognition of patterns in the environment, and the
ability to spontaneously form categories of events and event sequences (Diamond, 2002). The
next stage of rapid development of EF is in the preschool years (ages 4-6 years) and involves
rapid advancement in logical thought processes, verbal mediation, working memory, and
selective attention (Welsh et al., 1991). This second stage of rapid development is noteworthy for
the maturation of several different EF processes (Best et al., 2009), and has been studied
extensively for the past decade (see Isquith et al., 2005 for review). Additionally, it is during this
stage of development that EF become more integrated and increasingly related to self-regulatory
behaviors, which has been described as occurring partially due to the development of attention
(Diamond, 1991; Garon et al., 2008; Welsh & Pennington, 1988). The last stage of rapid
development of EF occur in adolescence and is characterized by further refinement of EF due to
pruning of the frontal neural systems (Luna et al., 2010).
Integral work by Senn, Espy, and Kaufman (2004) showed that relations among EF
processes change over the course of development. As part of a longitudinal study, children ages
2 to 6 years of age were assessed on measures of inhibition, working memory, and shifting.
When scores on a performance-based task were split based on age (i.e. ages 2-4, ages 5-6)
different patterns of relations were found. For the younger group, only inhibition predicted
problem solving on a performance-based task. However, for older children, only working
memory predicted problem solving on the same task. The authors concluded that these findings
demonstrate the differential course of development for EF processes. This work also
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demonstrates that various EF skills can be drawn on to solve complex problems depending on
the current developmental stage.
The EF abilities of children have been of great interest over the past decade, and research
examining EF in both typically developing and clinical groups in childhood and adolescence
have been ample. However, despite the multitude of research, the literature has significant
limitations that pose problems when determining the developmental trajectories of specific EF
processes. Much of the EF literature has focused on that second, rapid stage of EF development
in preschoolers, which not only paints an incomplete picture of the full developmental trajectory,
but also limits the extent to which conclusions about the sequences and mechanisms of
development across the trajectory occur. Despite inconsistencies in the literature with regards to
these methodological and theoretical issues, it has been demonstrated that inhibition improves
during the preschool years and shows significantly less change later in childhood (Romine &
Reynolds, 2005). On the other hand, working memory and shifting tend to show a more gradual
linear improvement throughout a child’s development and into adolescence (Kwon et al., 2002;
Luciana et al., 2005).
EF deficits have been observed across numerous pediatric medical and development
disorders, which is not surprising given the maturation of EF spans the entire course of childhood
and into young adulthood. Children with medical and/or developmental disorders are also
particularly at risk due to the complexity and widespread neurological underpinnings spanning
the cortical and subcortical structures (Makris et al., 2007; Miller & Cummings, 2007), such that
the very nature of the inter-connectivity of the prefrontal cortex with the rest of the brain
increases the likelihood that any insult to the brain is likely to result in poorer EF. For example,
despite controlling for IQ, EF deficits have been associated with several genetic disorders, such
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as Turner syndrome (Romans, 1997), NF1 (Remigereau et al., 2017), Fragile X syndrome
(Mazzocco et al., 1993), as well as acquired disorders, such as traumatic brain injury (Sykes et
al., 1997) and frontal lobe lesions (Eslinger et al., 1999). As previously indicated, EF deficits are
also common in certain developmental disorders, such as ADHD (Pennington & Ozonoff, 1996;
Barkley et al., 1997) and ASD (Pennington & Ozonoff, 1996; Bishop, 1993).
Developmental differences in EF have been proposed as central deficits in ADHD.
ADHD is one of the most common developmental disorders of childhood, with a prevalence
estimate of 7.2% (Thomas et al., 2015). Characterized by symptoms of inattention, hyperactivity,
and impulsivity, ADHD is thought to be sustained by excessive and inappropriate situational
motor behavior, limited inhibitory control of responses, and an inability to focus, sustain, and
switch attention (Barkley, 1997; Frank 1996; Biederman et al., 2006). Numerous authors have
proposed the notion that ADHD symptomatology arise from a primary deficit in EF (Barkley,
1997; Castellanos and Tannock, 2002; Pennington and Ozonoff, 1996). Behavioral inhibition, in
particular, has been defined as the primary deficit in ADHD (Barkley, 1997). Barkley’s (1997)
model refers to behavioral inhibition as interrelated processes of inhibiting a prepotent response,
stopping an ongoing response, and interference control. Deficits in behavioral inhibition are
related to secondary impairments in working memory, self-regulation, internalization of speech,
and reconstitution (Barkley, 1997, p. 68). In their formative meta-analytic review of the
neuropsychological correlates of ADHD, Pennington and Ozonoff (1996) found that children
with ADHD performed significantly worse than three comparison groups comprised of
individuals with conduct disorder, ASD, and Tourette syndrome on over two-thirds of the EF
measures administered. Specific weaknesses for individuals with ADHD were apparent on
measures of vigilance, processing speed, and motor inhibition. These areas of specific
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weaknesses have continued to be confirmed by other researchers in additional studies of children
with ADHD (Corbett et al., 2009; Shallice et al., 2002; Kasper et al., 2012), which is further
evidence that ADHD is characterized by deficits in vigilance and inhibitory control. However,
more global EF deficits in the areas of working memory, cognitive flexibility, and planning have
also been reported in children and adolescents with ADHD (Sergeant et al., 2002). In a
comprehensive meta-analytic review, Willcutt and colleagues (2005) determined that EF
impairment in the areas of inhibition, planning, vigilance, and working memory play an
important role in the neuropsychology of ADHD; however, EF weaknesses were neither
necessary nor sufficient to cause all cases of ADHD. While these results clearly reiterate the
notion that EF impairment is associated with ADHD and remain an important component to the
ADHD behavioral profile, the hypothesis that EF deficits alone are sufficient to cause ADHD in
all individuals is unsupported.
Assessment of Executive Functioning
Results from EF assessment can provide information that could not otherwise be obtained
relating to a child’s overall ability, motivation, and potential; and this is particularly true for
children and adolescents. Despite the vast utility of EF assessment in children with NF1,
selection of appropriate tools to assess EF can be challenging given the complex mechanisms of
EF across age groups. Furthermore, not only is the assessment of EF plagued with the issue of
finding appropriate measures to assess EF across a wide age range and span of development, but
it is also overwhelmed with validity issues. Both performance-based measures and functional
behavior rating measures are commonly used in clinical and neuropsychological assessments and
are intended to measure the same underlying construct of EF. Despite both being commonly
utilized, the most conventional method for assessing EF is through use of performance-based
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measures (Pennington & Ozonoff, 1996). Performance-based measures are typically conducted
in a highly structured one-on-one setting, making them advantageous for their controlled and
structured environment. Performance on these measures are typically based on the examinee’s
accuracy, response time, and processing speed under a time constraint.
One of the greatest advantages to using performance-based measures of EF can also be
considered a limitation. The highly structured, one-on-one setting that performance-based
measures are administered allows for the possibility of one to perform better than they would in
more realistic, less structured environments. The structured nature of a typical assessment does
not place high demands on EF, thus reducing the opportunity for observing behavior related to
more everyday EF (Holmes-Bernstein & Waber, 1997). Furthermore, it makes it even more
challenging to hone in on difficulties that are observed in less structured environments
(Salthouse et al., 2003). It has been posited that the highly controlled environment, itself, acts as
its own frontal lobe, allowing for more optimal performance than in a less structured
environment (Salthouse et al., 2003). A second issue with using these measures is involves task
impurity. EF measurement involves invoking cognitive processes within other domains during
tasks that assess EF due to the very nature of EF as a construct. In fact, it has been demonstrated
that many measures of EF involve non-executive processes as part of the task, such as color
naming in the Stroop task (Miyake & Friedman, 2012). Lastly, a third issue with using
performance-based measures involves the idea that novelty is a key characteristic of many EF
tasks; and therefore, the degree to which various EF tasks are novel to an individual varies
significantly depending on that individual’s personal experience. Different experiences likely
lend themselves to different strategies for the same task (Hughes, 2002). As such, this is likely
the reason that EF measures have been found to be weakly correlated among themselves,
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particularly over time or with one another (Hughes, 2002; Miyake et al., 2000). For these
reasons, a child’s everyday environment, such as in the home or at school, may provide more
useful venues for observing the true essence of aggregate everyday EF, making caregivers’
report of behaviors in these environments highly valuable.
Functional behavior rating scales are also commonly used to assess EF and are thought to
prevent some of the methodological issues that often accompany performance-based measures.
Within the past decade, several studies examining child populations have noted the clinical
utility of the Behavior Rating Inventory of Executive Function (BRIEF; Gioia et al., 2000) and
its ability to distinguish between clinical groups, such as children with ADHD, traumatic brain
injury, frontal lesions, and ASD (Toplak et al., 2012). Functional measures of EF are assumed to
measure behaviors that are significantly related with the processes that are assessed by
performance-based measures of EF. Functional measures can be completed by observers, such as
parents and/or teachers, and can also be completed by the child depending on his/her age. The
BRIEF (Gioia et al., 2000) is the most commonly utilized functional measure of EF. It is
composed of eight individual scales and three composite scores assessing behaviors on scales of
inhibition, shifting, emotional control, initiation, working memory, planning/organization,
organization of materials, and monitoring. The BRIEF has been demonstrated to adequately
capture the expected patterns of EF in diverse clinical populations and have correlated with
biological markers associated with executive function, thus, providing evidence of relations
between EF and real-world behavior (Isquith, Roth, & Gioia, 2013).
While ratings of everyday functional behavior provide useful insight into a child’s
typical, everyday behavior, there are issues that exist when relying on these measures alone.
First, raters completing ratings have limited control of environmental influences that could affect
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ratings. An individual who is described as having EF impairments in a highly demanding
environment might be described as having sufficient EF abilities in a less demanding
environment, for example. Second, given the integrative nature of EF, particularly within an
everyday context, functional rating scales make it difficult to parse out impairments in specific
EF processes compared to relatively narrower focused performance measures (Gioia et al.,
2016). Third, the observant/rater’s perspective requires consideration when interpreting
functional behavior, which lead to inconsistencies in reports from different informants (Dibartolo
& Grills, 2006).
Performance-based measures of EF and functional behavior rating scales are presumed to
assess the same construct, and thus, should be significantly positively correlated with each other;
however, results from several studies point to a different conclusion. Studies that have examined
relations between performance-based and functional measures of EF have generally reported
minimal to no convergence. As reported in a review by Toplak and colleagues (2013), of the 12
studies that have examined relations between the BRIEF with several commonly used EF
performance measures in childhood, there were “extremely weak” to no relations between
measures. Indeed, it has been argued that these two different types of measurements may assess
different underlying constructs of EF (Chevignard et al., 2012; Toplak et al., 2013).

Summary and Study Rationale

For the past decade, the presence of ADHD has increasingly emerged as a characteristic
feature of the NF1 neuropsychological phenotype. ADHD and EF abilities are closely
interrelated across many levels, skillsets, and tasks. While ADHD is characterized by EF deficits,
it is important to highlight that not every EF deficit stems from problems with attention or
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impulse control. This has been demonstrated through findings that children with NF1 evidence
EF deficits independent of a comorbid ADHD diagnosis. However, less is understood about what
factors contribute to EF performance in children with NF1. While ADHD is likely to explain
some of the difficulties in EF in children with NF1, evidence suggests that ADHD does not
explain all the variance. Examination of the relations between EF performance and attention,
cognitive functioning, anxiety and depression, various sleep factors, and SES, in children with
NF1 is warranted. In addition, while performance-based measures are useful in providing
information regarding a child’s ability under optimal conditions, functional behavior measures
can provide us with aggregate information on how the child typically functions day-to-day.
Relatedly, most NF1 studies examining EF in children have done so using performance-based
measures of EF, which may limit the extent to which difficulties with EF are detected. As such,
assessment of EF in children with NF1 using multiple methods is warranted.

Methods
Study Aims & Hypotheses
Aim 1: Characterize EF performance in our sample of children with NF1. Results
from both performance-based and functional measures of EF will be described. Specifically, the
number of children who display performance-based EF impairment (at least 1 standard deviation
below the mean) will be reported. The number of children with behavior in the “at-risk” and
“clinically elevated” range on the functional parent-reported EF measure will also be described.
In addition, the mean scores for all EF measures will be reported. It is hypothesized that children
with NF1 will display EF impairment on standardized performance-based measures. It is also
expected that functional executive dysfunction across EF scales on the BRIEF will be commonly
reported by parents.
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Aim 2: Correspondence between performance and functional measures. Relations
between scores obtained from EF performance-based measures and functional parent-reported
measure will be examined. Mean performance scores and the percentage of children who display
EF impairment (at least 1 standard deviation below the mean) on performance-based measures
will also be compared and contrasted with the number of children reported to demonstrate
behavior in the “at-risk” and “clinically elevated” range on the functional parent-reported BRIEF
to determine whether children with NF1 display impairment more on performance-based or
functional parent reported measures of EF. It is hypothesized that scores on EF performancebased and on functional parent reported measures will show small interrelations. It is also
expected that our sample of children with NF1 will display more difficulties based on functional
parent report compared to performance-based measures.
Aim 3: Examine potential neuropsychological, sociodemographic, and psychosocial
factors that contribute to EF performance.
Attention Problems. To assess whether attention problems are related to EF in our
sample of children with NF1, performance-based and functional EF measures will be examined
for children with NF1 with and without ADHD separately. In addition to examination of EF
performance based on ADHD diagnosis, the contribution of ADHD symptomatology will also be
examined using dimensional scales from a parent-reported measure. It is hypothesized that
children with NF1 will exhibit EF impairment, independent of ADHD diagnosis; however, it is
expected that EF performance and report of dimensional ADHD symptoms will be significantly
related.
General Cognitive Functioning. To examine the role of general cognitive functioning to
EF, general cognitive ability scores will be examined in relation to performance-based and
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functional EF. It is expected that general cognitive functioning and EF will be significantly
related in our sample of children with NF1.
Socioeconomic status and Maternal Education. Examination of SES and maternal
education in relation to EF on performance-based and functional EF measures will be conducted.
While exploratory in nature, given previous work in the typically developing population, it is
expected that SES and maternal education and EF performance will be significantly related in
our sample of children with NF1.
Anxiety and Depression. To examine the contributing role of internalizing problems to
EF performance, parent-reported anxiety and depression will be examined in relation to
performance-based and functional EF. While exploratory in nature, it is expected that anxiety
and depression symptoms will be significantly related to EF performance in our sample of
children with NF1.
Sleep. The role of sleep and the presence of sleep problems will be examined.
Performance-based and functional EF will be examined to determine whether children who meet
cut-off criteria for SRBD demonstrate significantly different EF performance compared to
children without SRBD. Specific sleep-related problems from the PSQ will also be examined in
relation to performance-based and functional EF. It is hypothesized that children who meet cutoff criteria for SRBD will display significantly more EF impairments and that sleep-related
problems will be related to EF performance.
Relative Contributions. Lastly, to get a sense of the degree to which ADHD, SES,
anxiety/depression, and/or the presence of sleep problems predict EF impairment in our sample
of children with NF1, two multiple regression analyses will be conducted. The first regression
will include the performance-based Toolbox Flanker as the dependent variable, given extensive
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literature supporting the notion that inhibitory processes are primary EF constructs and other EF
processes are highly associated to inhibition. The second regression will include functional
parent reported measure BRIEF GEC as the dependent variable. However, if high
intercorrelations among EF measures are present (r  .7), a composite performance-based EF
score may be calculated and used in the regression analysis as the dependent variable in place of
the Toolbox Flanker and BRIEF GEC. Specific predictors of the models will be determined
based on results of aforementioned analyses. This aim is exploratory in nature.
Participants
Participants included 40 children between the ages of 9 and 13 diagnosed with NF1 and
one parent of each child participant. Only children whose first and main language spoken in the
home was English were included in the study. Children whose first and main language were not
English were excluded given study measures and instructions were standardized and normed
using English-speaking populations. Children who had significant surgery requiring general
anesthesia within the 6 months prior to screening were excluded from this study, given that the
effects of general anesthesia could have an impact on performance on study measures.
Procedures
Recruitment of participants involved three methods. The first method involved sending
fliers describing the current study to participants who have participated in prior research and who
consented to be informed of future studies in the lab. Second, participants were recruited through
several Midwestern Neurofibromatosis Clinics. NF1 clinic directors were asked to share a
description of the study to families with children between the ages of 9 and 13 with a confirmed
diagnosis of NF1. Parents who were interested in participating or finding out more about the
study were provided with a flier and encouraged to contact the PI or study coordinator. The third
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method involved recruitment through the national Neurofibromatosis Research Registry.
Families within driving distance who had noted their interest in being contacted about possible
research opportunities on the registry were emailed a description of the study and a flier.

Participants who met eligibility requirements were scheduled for an evaluation at the
Child Neurodevelopment Research Lab (CNRL) at the University of Wisconsin-Milwaukee or in
a quiet hotel conference room near their home. Participants were consented and were given an
opportunity to ask questions or express concerns before agreeing to participate. Prior to the
assessment appointment, the consent form and questionnaires were mailed to the family for
parental completion. The questionnaires of interest for the study were designed to examine
ADHD symptoms, everyday EF abilities, sleep-related difficulties, and anxiety/depression
symptoms. Each child was administered an age-appropriate neuropsychological battery by a
trained member of the study team. Assessment sessions lasted approximately 4 hours for all
children, including time for breaks to minimize fatigue. All assessment measures were
administered to children in the same order. Parents were interviewed about their child’s behavior
during their child’s assessment in an adjacent room.

Measures

All measures chosen for this study were developed for use with children 9 to 13 years and
are widely used in pediatric assessment and research both in typically developing populations
and children with a variety of developmental disorders. All neuropsychological measures are
norm-referenced and have demonstrated strong psychometric properties, including good
reliability and validity. The measures selected were chosen to provide information about
children’s attention and EF abilities, as well as sociodemographic and psychosocial factors.
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These measures were selected to pick up on both obvious impairments, as well as more subtle
difficulties that are commonly found in children with NF1. A detailed description of each
measure is provided below, and a summary of the measures is provided in Table 2.

Differential Ability Scales-Second Edition: School-Age Form (DAS-II; Elliot, 1990).
The DAS-II is a commonly used, comprehensive measure of cognitive abilities for children ages
7-0 to 17-11. The DAS-II is empirically derived and demonstrates excellent internal consistency,
test re-test reliability and correlates highly with other commonly used measures of cognitive
abilities (Elliot, 1990). The DAS-II provides normative data collected on a large representative
national sample and contains excellent floor and ceiling levels, making it appropriate for children
with neurodevelopmental disorders. This measure yields an overall composite score called the
General Conceptual Ability (GCA) standard score (M = 100, SD = 15) that is equivalent to a
full-scale IQ score. The GCA is broken down into three cluster scores, including Verbal Ability,
Nonverbal Reasoning Ability, and Spatial Ability. In this study, participants completed the core
subtests for the School-Age Form (including Word Definitions, Verbal Comprehension,
Matrices, Sequential and Quantitative Reasoning, Recall of Designs, and Pattern Construction) to
yield a GCA. In addition, subtests for the Working Memory cluster (Recall of Sequential Order,
Recall of Digits Backward) were administered.
NEPSY – Second Edition: Auditory Attention/Response Set (NEPSY-II; Korkman,
Kirk, & Kemp, 2007). The NEPSY-II is a widely-used measure that assesses children’s
performance in areas of six theoretically derived domains, including Attention and Executive
Functioning, Language, Memory and Learning, Sensorimotor, Social Perception, and
Visuospatial function. Administration of selected subtests takes approximately 5-10 minutes and
is designed for children 3-16 years old. The Auditory Attention/Response Set (AA/RS) subtest
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from the Attention domain has two parts; Auditory Attention which was designed to assess
sustained, selective auditory attention and Response Set which was designed to assess shifting
and sustained attention skills. Both subtest parts yield an overall scaled score (M = 10, SD = 3).
Cogstate Research Battery (Cogstate; http://www.cogstate.com), selected subtests.
The Cogstate battery is a commercially available, computerized cognitive testing system
designed specifically for the use in research studies. Cogstate tasks have been shown to be highly
reliable and sensitive. The entire Cogstate testing battery targets a wide range of cognitive
domains, including processing speed, attention, EF, and social-emotional cognition. The Visual
Attention/Vigilance and Attention/Working Memory tasks were administered for the current
study, including the Identification Task (ID).The ID task, designed to assess simple visual
attention and vigilance and takes approximately 2 minutes to complete. The primary outcome
measure of ID is log transformed reaction time, in which lower times indicate better
performance. The One Back Task (ONB), designed to assess working memory and sustained
visual attention, was also completed. The ONB takes approximately 4 minutes to complete. The
primary outcome measure for ONB is Arcsine transformed accuracy, in which higher scores
indicate better performance. The ONB task also provides log transformed reaction time, in which
lower times indicate better performance. All Cogstate outcome scores were converted to z-scores
(M = 0, SD = 1) for analyses.
NIH Toolbox (http://www.nihtoolbox.org), selected subtests. The NIH Toolbox is a
comprehensive set of neurobehavioral measurements that quickly assess cognitive, emotional,
sensory, and motor functions. NIH Toolbox is based on a nationally representative sample and
has been validated to be psychometrically sound. For the current study, the List Sorting Working
Memory (LSWM), Dimensional Change Card Sort Test (DCCS), and Flanker Inhibitory Control
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and Attention Test (Flanker) tasks were administered. LSWM is a 7-minute working memory
task where participants recall and sequence different visually and orally presented stimuli. The
DCCS is a 4-minute measure of cognitive flexibility and attention. Pictures are presented varying
along two dimensions (e.g. shape and color) and participants are required to sort based on a cue
word on the screen. Flanker is a 3-minute attention and inhibitory control task where participants
are required to focus on a given stimulus while inhibiting attention to nearby stimuli. For the
Flanker, if accuracy levels were less than or equal to 80%, the final “total” computed score was
equal to the accuracy score. If accuracy levels for the participant reached more than 80%, the
reaction time score and accuracy score were combined (Zelazo et al., 2013). All NIH Toolbox
outcome scores were standard scores (M = 100, SD = 15).
Spence Children’s Anxiety Scale (SCAS; Spence, 1998). The SCAS is a parentreported measure designed to assess the severity of childhood anxiety symptoms. The SCAS
assesses six domains of anxiety including generalized anxiety, panic/agoraphobia, social phobia,
separation anxiety, obsessive compulsive disorder, and physical injury fears; and provides an
overall total anxiety score. The SCAS has been widely used in research and clinical contexts for
assessment purposes. While not a diagnostic measure, the SCAS was designed to provide an
indication of the nature and extent of anxiety symptoms to assist in the diagnostic process. Total
SCAS raw scores will be used for correlational analyses.
Pediatric Sleep Questionnaire (PSQ; Chervin et al., 2000). The PSQ is a parentreported measure of pediatric sleep disorder symptoms. The PSQ was designed as a broad
clinical screen for research purposes and has demonstrated good reliability and validity. The
presence of various sleep-related problems, as well as the overall Sleep-Related Breathing
Disorder (SRBD) scale was examined. The SRBD scale consists of 22 symptoms items from the
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PSQ that inquire about snoring frequency, loud snoring, observed apneas, difficulty breathing
during sleep, sleepiness, daytime behavior, and other pediatric obstructive sleep apnea features.
The SRBD scale was developed for clinical research purposes and has been validated against
polysomnography (Chervin et al., 2006). The number of 22 symptom-items endorsed positively
is divided by the number of items answered positively or negatively, so that missing responses
are excluded. The result is a proportion that ranges from 0.0 to 1.0. Scores >.33 are considered
positive and are suggestive of high risk for a pediatric sleep-related breathing disorder. This
threshold is based on a validity study (Chervin et al., 2000) that suggested optimal sensitivity and
specificity at the 0.33 cut-off.
Kiddie Schedule for Affective Disorders and Schizophrenia – Present and Lifetime
(KSADS-PL; Kaufman et al., 1997)- ADHD Section. The KSADS-PL is a semi-structured
clinical interview administered to parents. The ADHD section was administered to parents to
assess ADHD symptomatology, including inattention and hyperactivity/impulsivity symptoms.
Behavior Assessment System for Children – Second Edition (BASC-2; Reynolds &
Kamphaus, 2004). The BASC-2 is a commonly used screener of childhood problem behaviors.
The BASC-2 was administered to parents. Scales of interest for the current study include the
Anxiety, Depression, Somatization, and Withdrawal content scales, as well as the Internalizing
Problems composite scale. The BASC-2 yields t-scores (M = 50, SD = 10).
Behavior Rating Inventory of Executive Function (BRIEF; Gioia et al., 2000). The
BRIEF is a parent rating scale developed to provide a glimpse into everyday behaviors
associated with EF in the home and school environments. The BRIEF yields 8 clinical scales:
Inhibit, Shift, Emotional Control, Initiate, Working Memory, Plan/Organize, Organization of
Materials, and Monitor. These clinical scales form two broader indexes, the Behavioral
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Regulation Index (BRI) and the Metacognition Index (MI), and an overall score, the Global
Executive Composite (GEC). The BRIEF yields t-scores (M = 50, SD = 10). Normal scores
include t-scores ≤ 59, at-risk scores include t-scores 60-64, and clinically elevated scores include
t-scores ≥ 65).
Conners Parent Short Form, Third Edition (Conners-3 Short; Conners, 2008). The
Conners-3 Short is a parent reported measure that assesses ADHD and its most common
comorbid problems and disorders for children and adolescents 6-18 years. The Conners-3 Short
is meant to assess children’s behavior across multiple settings. For the purposes of this study,
scales assessed include the ADHD Inattentive and ADHD Hyperactive-Impulsive scales. The
Conners-3 Short yields t-scores (M = 50, SD = 10).
Hollingshead Four-Factor Index of Socioeconomic Status (Hollingshead;
Hollingshead, 1975). The Hollingshead is a survey designed to measure the SES of an
individual based on four domains: marital status, employment status, educational attainment, and
occupation. Information gathered from children’s parent(s) based on these domains were coded
by examiners to calculate a total parental SES score. The Hollingshead is widely used in
psychosocial research and has demonstrate adequate internal consistency and strong crosssectional convergent validity based on 1970 census data.
Background Questionnaire. The CNRL Background Questionnaire is a comprehensive
parent-completed questionnaire used to collect demographic information, which may aid in
analysis of data (examining differences based on, for example, parental education or child
medical history).
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Results
The data were analyzed using IBM SPSS for Mac, version 26. Spearman’s rho was used
when correlational analyses were conducted and interpretations of correlation effect size (Cohen,
1988) are as follows: small = 0.1 – 0.3; medium = 0.3 - 0.5; large = 0.5 – 1. Given the number of
comparisons made, the False Discovery Rate approach (Benjamini & Hochberg, 1995; Pike,
2011) was used to determine a q-value adjusted for the number of comparisons within each set of
analyses with multiple comparisons, and these q-values were compared with alpha = .05 to
determine statistical significance.

Demographics and Individual Differences. See Table 3 for complete participant
demographics. No significant differences between sporadic and familial etiology of NF1 were
evident when examining SES, t(39) = -1.84, p = .089; mother education, t(39) = -1.98, p = .844;
general cognitive functioning (DAS-II GCA), t(39) = .462, p = .616, or ADHD diagnosis, t(39) =
.771, p = .253. There were also no significant differences in scores on any performance-based EF
measure between sporadic and familial etiology of NF1, t(39) = .045 – 1.42, p = .163 - .965; nor
on any functional EF BRIEF scale or index, t(39) = .170 – 1.62, p = .113 - .866.

EF in Children with NF1.

Aim 1: Characterize EF performance in our sample of children with NF1. A
summary of parent-reported BRIEF scores sampling functional EF is detailed in Table 4. Group
mean scores fell in the average range for all domain scores; however, independent one-sample ttests indicated significantly higher scores than the normative mean on the Inhibit, Initiate,
Working Memory, Plan/Organize, Organization of Materials, and Monitor domains; and on the
Behavioral Regulation, Metacognition, and GEC indices. No significant differences in scores
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from the normative mean were evident when examining the Shift and Emotional Control
domains. Figure 1 details the distribution of normal (≤ 59), at-risk (60-64), and clinically
elevated (≥ 65) problems reported by parents on the BRIEF. On the BRIEF GEC, 6 children
(15%) were rated as demonstrating EF difficulties in the “at-risk” range; and 12 children (30%)
were rated as demonstrating EF difficulties in the clinically elevated range. There were no
significant relation between BRIEF scale scores and age, rho(40) = -.130 - .194, p = .961 - .234,
and no significant effect of sex, t(39) = .033 – 1.23, p = .216 - .974.

A summary of scores on EF performance-based tasks is presented in Table 5. Group
mean scores fell in the broadly average range across measures. Independent one-sample t-tests
revealed significantly lower scores than the normative mean on DAS-II RSO, DAS-II RDB,
Toolbox DCCS, Toolbox Flanker, NEPSY-II RS, and NEPSY-II AA/RS. Figure 2 details the
distribution of performance-based EF scores 2 SD above the mean, 1 SD above the mean, within
1 SD of the mean, 1 SD below the mean, and 2 SD below the mean. Based on frequency of
difficulties, children with NF1 demonstrated the most difficulty on Toolbox Flanker, with 14
children (39%) with scores 1 SD below the mean; and 3 children (8%) with scores 2 SD below
the mean. Performance on Cogstate ID had moderate significant associations with age, rho(39) =
-3.72, p = .020. No additional relations between age and performance-based measures were
evident. No sex difference in scores on performance-based EF tasks was evident, t(36-39) = .172
– 2.06, p = .058 - .865.

When comparing and contrasting rates of difficulties between performance-based and
functional EF, the percentage of children showing performance one standard deviation or more
below the mean on tasks of inhibition, working memory, and cognitive flexibility/shifting across
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measures was examined. Results revealed higher rates of impairment on the BRIEF compared to
performance-based measures. Specifically, a chi-square goodness-of-fit test indicated that there
was a statistically significant differences in the proportion of identified EF difficulties across
measures, χ2 (2, n = 40) = 42.23, p = <.001, when examining rates of impairments (1 SD below
the mean) on the BRIEF Inhibit scale (48%) compared to NIH Toolbox Flanker (44.4%); the
BRIEF Working Memory scale (37.5%) compared to NIH Toolbox LSWM (18.9%); and the
BRIEF Shift scale (25%) compared to NIH Toolbox DCCS (21.6%).
Aim 2: Correspondence between performance and functional measures. To compare
EF scores from performance-based and functional measures, bivariate Spearman correlations
were conducted. See Table 6. Results revealed medium, negative correlations between
performance on the Toolbox DCCS and the BRIEF Monitor scale, rho(37) = -.519, p =.044. No
additional significant relations between performance-based and functional measures of EF were
evident.
Aim 3: Examine potential neuropsychological, sociodemographic, and psychosocial
factors that contribute to EF performance.
Attention. Bivariate Spearman correlations were also used to examine relations between
parent-reported dimensional ADHD symptoms on the Conners-3 Short and functional parentreported EF. Results revealed medium to large positive relations between dimensional inattentive
symptoms and BRIEF GEC, (rho(40) = .628, p = < .001); BRIEF BRI and MI, (rho(40) = .437 .493, p = .002 - .009); Monitor, (rho(40) = .596 8, p = < .001); Working Memory, (rho(40) =
.558, p = < .001); Inhibit, (rho(40) = .626, p = < .001); Plan/Organize, (rho(40) = .423, p =
.009); and Initiate, (rho(40) = .373, p = .024) scales. When examining parent report of
inattentive symptoms, examination of relations on performance-based EF tasks revealed a
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negative, moderate correlation with NEPSY RS, (rho(40) = -.407, p = .049). No additional
relations were apparent. Parent-reported hyperactive/impulsive symptoms from the Conners-3
Short were also explored in relation to parent-reported functional EF. Results revealed medium
to large positive correlations between hyperactive/impulsive symptoms and BRIEF GEC,(
rho(40) = .389, p = .027); BRI,( rho(40) = .382, p = .027); MI, (rho(40) = .455, p =.008);
Inhibit, (rho(40) = .545, p = .001); Working Memory, (rho(40) = .491, p = .005); Monitor,
(rho(40) = .473, p = .007); and Plan/Organize (rho(40) = .368, p = .031). No significant relations
were evident when examining associations between performance-based EF and parent report of
hyperactive/impulsive symptoms.
To further examine the extent to which ADHD symptomatology is related to EF in our
sample of children with NF1, group differences between children diagnosed with NF1 + ADHD
and children with NF1 without ADHD were explored using multivariate analysis of variance.
See Table 7. No significant effect of ADHD diagnosis was observed when examining scores on
performance-based EF tasks (F(11, 24) =.910; p = .545; Wilks’ λ = .706). When examining
functional EF on the BRIEF, group differences were evident between children with and without
ADHD, (F(11, 28) = 3.89; p = .002; Wilks’ λ = .396). See Table 8 for group differences on the
BRIEF. The distribution of BRIEF scores by group is illustrated in Figure 3.
General Cognitive Functioning. To better understand what neuropsychological
variables could contribute to EF in children with NF1, relations between DAS-II GCA and EF
variables were investigated using bivariate Spearman correlations. Results revealed medium to
large positive correlations between DAS-II GCA and Cogstate ONB Accuracy, rho(39) = .548, p
= <.001; LSWM, rho(37) = .581, p = < .001; DAS-II RDB, rho(40) = .535, p = <.001; Flanker,
rho(36) = .506, p = .004; and DAS-II RSO, rho(40) = .481, p = .004. Examination of relations
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between DAS-II GCA and parent-reported EF on the BRIEF did not reveal any significant
associations (rho = .001 - .197, p = .222 - .996).
SES & Maternal Education. To better understand the extent to which sociodemographic
variables contribute to EF in children with NF1, relations between SES and level of maternal
education were examined in relation to EF using Bivariate Spearman correlations. When
examining performance-based EF, no significant associations were present with SES, (rho = .030
- .227, p = .679 - .857), nor maternal level of education, (rho = .005 - .161, p = .812 - .976). In
examination of parent-reported functional EF on the BRIEF, no significant associations were
apparent in relation to SES, (rho = .017 - .272, p = .531 - .917), nor maternal level of education
(rho = .040 - .236, p = .687 - .805).
Depression and Anxiety. To better understand the extent to which psychosocial
variables contribute to EF in children with NF1, parent-reported depression symptoms on the
BASC-2 were examined. Bivariate Spearman correlations were conducted examining relations
between the BASC-2 Internalizing Problems scale and performance-based and functional EF. No
significant relations were evident on performance-based EF; however, medium to large positive
correlations were evident on the BRIEF Emotional Control (rho(40) = .557, p = <.001); Shift
(rho(40) = .502, p = .005) scales; and the BRI (rho(40) = .481, p = .007). Bivariate Spearman
correlations were also conducted to examine relations between the BASC-2 Depression scale and
performance-based and functional EF. No significant relations were evident on performancebased EF when examining the BASC-2 Depression scale; however, medium to large positive
correlations were evident for the BRIEF Emotional Control (rho(40) = .653, p = <.001); Shift
(rho(40) = .460, p = .011) scales; and the BRI (rho(40) = .514, p = .005) and GEC (rho(40) =
.408, p = .024).
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Bivariate Spearman correlations were also conducted to examine parent-reported anxiety
symptoms on the SCAS in relation to EF. Results revealed no significant relations between
anxiety on the SCAS and performance-based EF; however, medium to large positive correlations
were evident for the BRIEF Emotional Control (rho(40) = .535, p = <.001) and Shift (rho(40) =
.683, p = <.001) scales; BRI (rho(40) = .572, p = <.001); and GEC (rho(40) = .429, p = .016).
Sleep. To better understand the extent to which sleep difficulties contribute to EF in
children with NF1, parent report of various sleep-related difficulties on the PSQ were examined.
In examination of relations to performance-based EF, parent report of restlessness during sleep
did not reveal any significant correlations. Bivariate Spearman correlations revealed medium to
large correlations between restlessness and functional parent-reported EF on the BRIEF
Emotional Control (rho(40) = .543, p = <.001); Monitor (rho(40) = .478, p = .007); Shift
(rho(40) = .407, p = .018); Inhibit (rho(40) = .409, p = .018) scales; and the BRI (rho(40) =
.509, p = .005) and GEC (rho(40) = .416, p = .018). Examination of relations between difficulty
falling asleep at night and both performance-based and functional EF did not reveal any
significant correlations (rho(40) =.008 - .323, p = .143 - .981). For performance-based EF,
bivariate Spearman correlations revealed a negative medium correlation between snoring during
sleep and performance on NIH Toolbox ONB Speed, (rho(36) = -.496, p = .025). For functional
EF using the BRIEF, snoring during sleep was significantly related to the BRIEF Monitor scale
(rho(40) = .501, p = .022), with a medium positive correlation. No additional relations to
snoring during sleep were evident.
To further explore the extent to which sleep-related difficulties are related to EF in our
sample of children with NF1, group differences between children who met cut-off criteria for a
SRBD on the PSQ and children who did not were explored. A total of 14 children (35%) met
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cut-off criteria for SRBD based on parent report of sleep and daytime behavior. No significant
effect of group was observed when examining scores on performance-based EF tasks (F(11, 24)
=.635; p = .782; Wilks’ λ = .775). There was also no significant effect of group when examining
functional EF on the BRIEF, (F(11, 28) = 1.87; p = .088; Wilks’ λ = .576); however, when
dependent variables were considerately separately, significant differences between groups were
evident on the BRIEF Inhibit, Working Memory, and Monitor scales; and MI. See Table 9. The
distribution of BRIEF scores by group is illustrated in Figure 4.
Relative Contributions. To further explore the extent to which various factors contribute
to EF in children with NF1, standard multiple regressions were conducted. First, a regression
was conducted to investigate predictive variables to functional, parent-reported EF on the BRIEF
GEC. Predictors of the model included overall cognitive functioning (DAS-II GCA), SES,
ADHD diagnosis, sleep-related breathing difficulties (SRBD cut-off criteria from the PSQ),
anxiety (SCAS Total Anxiety), and depression symptomatology (BASC-2 Depression scale).
Results indicated that these variables were significant predictors of parent-reported, functional
EF on the BRIEF GEC; F(6, 33) = 5.51, p = <.001. Upon examination of the unique contribution
of each variable in predicting BRIEF GEC scores, BASC-II Depression scores (β = .408; t =
2.79; p = .009) and ADHD diagnosis (β = .312; t = 2.21; p = .034) uniquely contributed to
BRIEF GEC.
Next, a standard multiple regression was conducted to investigate predictive variables to
performance-based scores on the NIH Toolbox Flanker. Predictors of the model were the same
as for functional EF and included overall cognitive functioning (DAS-II GCA), SES, ADHD
diagnosis, sleep-related breathing difficulties (SRBD cut-off criteria from the PSQ), anxiety
(SCAS Total Anxiety), and depression symptomatology (BASC-2 Depression scale). Results
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indicated that these variables were not significant predictors of performance on the NIH Toolbox
Flanker task; F(6, 29) = 1.34, p = .273. Upon examination of the unique contribution of each
variable in predicting performance-based scores on the Flanker, DAS-II GCA scores uniquely
contributed, (β = .397; t = 2.40; p = .023)
Discussion

Despite well-documented rates of executive dysfunction in children and adolescents with
NF1, to date there exists only a preliminary understanding of factors that may contribute to
executive functioning difficulties in children and adolescents with NF1. ADHD has increasingly
emerged as a characteristic feature of the NF1 neuropsychological phenotype, and while ADHD
typically includes deficits in certain aspects of EF, prior research has lent support to the notion
that children with NF1 display EF impairments independent of a comorbid ADHD diagnosis
(Huijbregts et al., 2012; Lion-Francois et al., 2017; Payne et al., 2012). In the current study, we
sought to characterize EF across performance-based and functional measures and compare and
contrast rates of difficulties across the two measurement methods. This multi-method design
allowed for investigation into the utility of parent-reported information on how children with
NF1 typically function on a daily basis, in conjunction with formalized performance-based
measures of EF. As hypothesized, children with NF1, as a group, displayed EF impairment on
standardized performance-based measures, and functional EF difficulties were commonly
reported by parents. While EF difficulties were seen across performance-based and functional EF
measures, only minimal associations were found between the two measure types, consistent with
previous literature examining performance-based and functional EF measures. As expected, our
sample of children with NF1 displayed more difficulties based on functional parent report
compared to performance-based measures. Higher rates of difficulties were apparent based on
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parent report of functional inhibition, working memory, and cognitive flexibility/shifting,
compared to the level of difficulty observed on performance-based EF measures.

In addition, the present study examined potential contributing effects of SES, general
cognitive functioning, attention, internalizing problems, and sleep to EF scores across functional
and performance-based measures of EF. Contrary to our hypothesis, no significant relations
between any EF measure, performance-based or functional, were evident when examining SES.
The present study found that general cognitive functioning was associated with performancebased working memory tasks and an inhibition task. No additional relations to general cognitive
functioning were evident when examining other performance-based EF tasks. No relations to any
functional EF scales was evident. Over one-third of children with NF1 met diagnostic criteria for
ADHD. Similar to findings from previous studies, the present study found that children with NF1
as a group demonstrate similar EF profiles on performance-based measures, independent of
ADHD diagnosis. However, as expected, on functional parent reported measures of EF, children
with NF1 and ADHD demonstrated significantly higher levels of executive dysfunction
compared to children with NF1 without ADHD. Contrary to our original hypothesis, parent
report of internalizing problems was not related to EF on performance-based measures; however,
relations between depression and anxiety symptomatology and parent report of functional
emotional control, shifting/cognitive flexibility, and overall behavioral regulation were found. As
hypothesized, specific sleep-related difficulties were significantly related to EF in the present
study. Parent report of restlessness and snoring was associated with functional EF in our sample
of children with NF1. Children who were reported to snore regularly had slower reaction times
on a performance-based working memory task. Group differences between children with NF1
who met criteria for SRBD and those who did not were apparent when examining parent report
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of functional inhibition, working memory, and self-monitoring difficulties. Potential
explanations for findings will be provided below, along with limitations, future directions, and
implications.
Characterization of EF. In line with previous research, the present study found that
children with NF1, as a group, demonstrated difficulty on performance-based and functional EF
measures. Specifically, functional difficulties compared to the normative mean were apparent on
scales sampling inhibition, initiation, working memory, planning/organization, organization of
materials, and self-monitoring. Half of parents reported functional difficulties related to
organization of materials; 45% reported self-monitoring difficulties; 42.5% reported
planning/organization difficulties; 37.5% reported working memory and initiation difficulties,
and 32.5% reported inhibition difficulties. The rates of functional EF difficulties in the present
study are somewhat lower than previously reported in the NF1 population. Payne and colleagues
(2011) found rates of working memory, self-monitoring, and planning/organization difficulties to
be nearly 60% in their sample of children and adolescents with NF1. The difference in reported
rates of functional difficulties between the present study and Payne and colleagues (2011) may
be due to differences in sample size and age ranges. The present study, which used a relatively
smaller sample, was designed to focus on the school-age years spanning 4 years (ages 9-13).
Payne and colleagues (2011) examined the functional EF of children spanning 10 years (ages 616) and had a significantly larger sample size. It is possible that these differences explain the
difference in rates of functional difficulties. The present study found particularly high rates of
parent-reported difficulties with organization of materials. This finding differs from previous
research in preschool children with NF1 that has demonstrated working memory deficits to be
the most prevalent and notable parent-reported difficulty (Casnar & Klein-Tasman, 2017;
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Sangster et al., 2011); however, it is important to consider these findings from a developmental
perspective. Given that working memory is considered a foundational EF process, and rapid
development typically occurs in the preschool-years (Welsh et al., 1991), it is reasonable to
consider that working memory abilities may be particularly vulnerable in children with NF1
during the preschool years. In school-aged children, as task demands increase, secondary EF
processes such as organization, remain in a developmental phase and thus, may be more
susceptible to day-to-day difficulties. As children progress through various developmental
stages, EF becomes increasingly differentiated into a dissociable, but related set of skills.
While more difficulties were apparent based on parent functional report of day-to-day
behavior, difficulties compared to the normative mean were also apparent on performance-based
working memory, inhibition, and cognitive flexibility/shifting tasks. Twenty-two percent of
children with NF1 demonstrated difficulty based on a performance-based working memory task;
21.6% demonstrated difficulty on a cognitive flexibility/shifting task; and 37.5% to 48.6%
demonstrated difficulty on performance-based inhibition tasks. It is evident that our sample of
children with NF1 demonstrated particularly high rates of inhibitory control difficulties, with
nearly 50% of children demonstrating such difficulties. This finding suggests that the NIH
Toolbox Flanker task is an especially sensitive measure in identifying performance-based EF
difficulties. This finding is consistent with previous studies that have found that children with
NF1 make significantly more inhibitory errors compared to control groups of typically
developing children (Gilboa et al., 2011; Isenberg et al., 2013). Our results also mirror previous
studies that have found greater incidence of impulsivity on Go/No-Go tasks compared to
typically developing children (Ribeiro et al., 2015). Furthermore, findings from functional MRI
(fMRI) studies in children with NF1 have revealed disturbances within neural networks
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associated with working memory (Shilyansky et al., 2010) and inhibition (Pride et al., 2017),
suggesting greater incidence of working memory and inhibition deficits in children with NF1.

Correspondence between performance and functional measures. In line with findings
from several previous investigations (Toplak et al., 2009; Gioia et al., 2002, Bodnar et al., 2007),
the current study found only minimal relations between scores on performance-based EF
measures and parent reported, functional EF. Findings indicated that only parent report of
functional self-monitoring was associated with performance-based cognitive flexibility/shifting
on a standardized task, such that children with NF1 who demonstrated more difficulty on the
performance-based cognitive flexibility/shifting measure were rated by their parents as
experiencing more day-to-day functional self-monitoring difficulties. No additional relations
between performance-based and functional EF were present in the current study. This finding
lends further support to the suggestion that performance-based and parent-reported functional
measures assess different underlying constructs of EF. Furthermore, the vastly different settings
in which EF is assessed between performance-based and functional EF is noteworthy. Highly
structured settings may allow for individuals to perform better than they would typically on a
day-to-day basis in their typical environment, thus limiting the extent to which difficulties are
observed (Holmes-Bernstein & Waber, 1997; Salthouse et al., 2003). As hypothesized and
consistent with previous research, the present study found significantly higher rates of inhibition,
working memory, and cognitive flexibility/shifting impairment on our functional, parentreported measure in direct comparison to rates on performance -based measures. This is in line
with the notion that performance-based EF tasks were designed to detect EF impairments in the
low ability level and may not be helpful in differentiating among children’s performances across
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a full range of ability. Furthermore, the optimal setting in which performance-based EF tasks are
conducted are likely to limit the extent to which more subtle deficits may exist in a functional
capacity on a day-to-day basis.

Contributions to Performance and Functional EF
Attention: As expected and given the overlap in executive dysfunction and ADHD, the
present study found that both dimensional and categorical ADHD symptomatology were related
to EF. When examined dimensionally, both parent-reported inattentive and
hyperactive/impulsive symptoms were related to parent report of functional difficulties with
working memory, self-monitoring, inhibition, and planning/organization. Dimensional
inattentive symptoms were also related to parent report of functional parent report of difficulties
with initiation. In addition to functional EF, dimensional ADHD inattentive symptoms were also
related to a performance-based inhibition task. Despite the strong theoretical overlap, the present
study did not find any relations to dimensional ADHD hyperactive/impulsive symptoms and
performance-based EF. This may be due to the optimal nature of the highly structured
environment in which performance-based tasks are completed, with clear instructions and
specific goals, thus reducing the opportunity to observe more typical behavior.
Thirty-seven percent of children with NF1 in the current study met diagnostic criteria for
ADHD, which is consistent with previously reported frequencies of ADHD in NF1 (Hyman et
al., 2005; Koth, Cutting, & Denckla, 2000). Group differences between children with NF1 +
ADHD and children with NF1 without ADHD were evident when examining parent report of
functional inhibition, emotional control, working memory, planning/organization, and overall
behavioral regulation, suggesting that children with comorbid ADHD experience more day-to-
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day, functional difficulties in these areas compared to children without ADHD. This finding is
consistent with the very nature of a diagnosis of ADHD, which requires report of functional
impairment across environments for diagnosis.
In the present study, there were no significant group differences in EF scores on
performance-based tasks between children with NF1 + ADHD and children with NF1 without
ADHD. These findings are in line with previous investigations that have demonstrated that
children with NF1 with comorbid ADHD generally do not perform worse than children with NF1
without ADHD (Hyman et al., 2005; Roy et al., 2010). Again, given the highly structured
environment in which performance-based tasks are completed, it may be that subtle difficulties,
which are more apparent day-to-day, are not observable and limiting in an optimal setting.
General Cognitive Functioning: In the current study, overall general cognitive
functioning was associated with performance on all three performance-based working memory
tasks, as well as a performance-based inhibition task. No additional relations to any
performance-based EF task or parent reported, functional EF were evident. In general, previous
literature has been inconsistent as to the relations between IQ and EF. In both the adult and
pediatric populations, there is evidence that some EF processes tend to be more related to overall
cognitive functioning/IQ compared to others. Working memory, in particular, tends to be one of
the EF processes that has had the most robust associations with overall IQ in both the adult and
pediatric populations. Friedman and colleagues (2016) suggested that the processes involving in
working memory, including sustaining attention to process relevant information, ignoring
irrelevant information, and updating and reworking information, corresponds to previous
definitions of intelligence, and thus explain why these two constructs are so strongly related.
Still, other studies have found no correlation between IQ and several performance-based EF
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tasks in school-aged children (Welsh, Pennington, Grossier, 1991). Other researchers have
highlighted the moderating effect of IQ on EF, particularly at higher IQ levels (Baron, 2003;
Mahone et al., 2002). The lack of relations between overall cognitive functioning and parent
reported, functional EF may be explained by the differing nature of performance-based and
functional EF measures. Performance-based measures are cognitive measures, whereas
functional EF measures involve descriptions and observations of behaviors. In addition, in the
present study, overall cognitive functioning was obtained on the same day performance-based EF
was obtained. In contrast, parent-reported functional EF is considered aggregate information
taking into account behavior over the past 6 months. With this in mind, it seems plausible that
performance-based EF tasks would be more likely to be associated with overall cognitive
functioning, compared to functional EF.
SES & Maternal Education: The present study found no relations between any EF
measure, performance-based of functional, to SES or maternal education. To date there are no
studies that examine contributions of SES or maternal education to EF in children with NF1;
however, this finding is in contrast to the typically developing literature which has consistently
demonstrated positive relations between SES and EF and has found SES to be predictive of EF
performance (Lawson, Hook, & Farah, 2018). While much of the SES and EF literature has
focused on emerging EF in preschool and young ages, findings from studies of EF development
during the early to middle childhood years have suggested that SES disparity in EF remains
consistent across these ages (Hackman et al., 2015). There a few potential explanations for the
lack of relations between SES and EF in the current study. Studies that have examined relations
between SES and cognitive and neuropsychological functioning in children with learning
disabilities have found differing relations depending on the aspect of functioning examined
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(Morrison & Hinshaw, 1988). Specifically, while SES was significantly related to intelligence
and achievement scores, SES was not related to scores on measures assessing speed naming,
visual and spatial sequencing, and visual motor integration, suggesting that socioeconomic
factors are not able to account for the variability in neuropsychological performance. The finding
that SES is not related to EF performance and ratings in our sample of children with NF1 may be
indicative of the extent to which executive dysfunction impacts school-aged children with NF1
as a group, independent of SES. With this in mind, the potential for a lack of positive relations
seems possible for children with NF1. It is also plausible that the present study did not have a
broad enough SES range to pick up on relations between SES and EF and, paired with our
relatively small sample size, may have hindered our ability to identify significant results.

Depression & Anxiety: Contrary to our hypothesis, parent report of overall internalizing
problems, and individually, depression and anxiety symptomatology, were not related to
performance-based EF in the current study. Previous investigations of typically developing
children have found high rates of internalizing problems in children and adolescents with EF
impairments and ADHD (see Craske, 2012 for review). Previous studies of children and
adolescents with depression have found associated inhibition and working memory impairments
using performance-based EF measures (Brooks et al., 2010; Maalouf et al., 2011). It has also
been demonstrated that children and adolescents with anxiety perform worse on performancebased working memory tasks and on cognitive flexibility measures (Toren et al., 2000; Emerson,
Mollet & Harrison, 2005). Furthermore, relations between poorer working memory abilities and
anxiety have been found in samples of participants without clinical levels of anxiety (Ursache
and Raver, 2014), suggesting that even subtle, more task-dependent anxiety impacts EF. Despite
the lack of significant findings in relation to performance-based EF, results from the current
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study revealed that parent report of internalizing symptoms, and individually, depression, and
anxiety symptomatology were significantly related to parent report of affective aspects of EF on
scales sampling emotional control, shifting/cognitive flexibility, and overall behavioral
regulation. Depression was also significantly associated with EF related to behavioral regulation
on the parent-reported, functional measure. Our findings mirror results from neuroimaging and
brain injury research that has demonstrated overlapping brain structures and networks to be
implicated in the regulation of behavior and in the regulation of emotion (Zelazo & Cunningham,
2007). Given the concurrent nature of the present study, it is not possible to determine whether
EF difficulties in children with NF1 increase risk for internalizing problems, or if internalizing
problems increase risk for EF difficulties. More likely, however, is that these difficulties are
bidirectionally influenced, given the overlap in these processes and shared brain involvement in
the prefrontal cortex. Regardless, given previous research suggesting increased risk for anxiety
and depression in children and adolescents with NF1 (Johnson et al., 1999; Graf et al., 2006;
Barton and North, 2007), and results from the current study that suggest associations with
emotional control and self-regulation, children with NF1 may benefit from targeted prevention and
intervention efforts aimed at supporting cognitive self-regulatory abilities (Riggs et al., 2006).

Sleep: As expected, the current study found that certain sleep-related difficulties, such as
restlessness and snoring during sleep, as reported by parents, were significantly related to parent
report of functional EF. While no previous studies have examined relations between specific
sleep-related factors to EF in children with NF1, there is evidence to suggest increased
hyperactivity and emotional challenges for children with NF1 who were reported to have high
sleep disturbance (Johnson et al., 2005). Specifically, the present study found that children with
NF1 who were rated by their parents as having difficulties on a daily basis related to emotional
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control, self-monitoring, shifting/cognitive flexibility, inhibition, behavioral regulation, and
overall EF were reported by their parents as struggling with restlessness during sleep. The
present study also found that children with NF1 who were reported to have difficulty snoring
during sleep were rated by their parents as having functional self-monitoring challenges on a
daily basis. Snoring was also significantly related to speed of responses on a performance-based
working memory task, such that children who were reported to struggle with snoring during
sleep tended to demonstrate slower response times. This finding is consistent with research that
has demonstrated that sleep disordered breathing involving snoring is associated with poor
performance on cancellation tasks that require speed (Beebe, 2006). Despite this identified
association to performance-based EF performance, the current study did not find any additional
relations to restlessness, snoring, or difficulty falling asleep on any performance-based EF
measures, suggesting that children with NF1 who may struggle with restless sleep are adequately
able to inhibit impulses, monitor behavior, and think flexibly on tasks in a one-on-one
environment under optimal conditions.

As hypothesized, and given previous findings by Licis and colleagues (2013) that
revealed increased incidence of sleep difficulties in children and adolescents with NF1, the
current study found that 35% of children with NF1 met cut-off criteria for a sleep-related
breathing disorder (SRBD) based on parent-report of sleep and daytime behavior. SRBDs,
characterized by abnormal respiration during sleep, include conditions such as obstructive sleep
apnea, upper airway resistance syndrome, and obstructive hypopnea syndrome. It has clearly
been demonstrated that SRBDs can have a profound impact on daytime behavior, particularly in
the developing child. Group differences between children with NF1 who met criteria for SRBD
and those that did not were apparent when examining parent report of functional inhibition,
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working memory, and self-monitoring difficulties. The present study did not find differences in
performance-based EF when comparing children with NF1 who met criteria for SRBD and those
that did not, suggesting relatively limited impact of sleep related problems on EF performance
under optional conditions in a one-on-one setting. Overall, our findings mirror results from
several studies that have concluded there is evidence of worsened EF performance for children
meeting criteria for a pediatric sleep disorder based on functional ratings, but less evidence to
support poorer EF performance when using objective performance-based measures (see
Mietchen et al., 2016 for review).

Implications

Overall, results from the present study confirm that EF difficulties are a characteristic
feature of the NF1 cognitive phenotype, are not simply a consequence of comorbid ADHD, and
interfere with the day-to-day functioning of children and adolescents with NF1. Results from the
current study also demonstrate the need to consider EF difficulties in the context of co-occurring
internalizing problems and sleep-related difficulties. While clinicians are likely to screen for the
presence of depression or anxiety symptoms as part of a neuropsychological evaluation, they
may be less likely to screen for sleep-related breathing difficulties, such as snoring or heavy
daytime breathing. Our finding that children with NF1 who met criteria for a sleep-related
breathing disorder experience more functional impairments in inhibition, working memory, and
self-monitoring compared to children with NF1 without sleep-related breathing difficulties is
noteworthy. Neurocognitive, behavioral, and emotional dysfunction, as well as reduced academic
achievements are well-characterized comorbidities in children with sleep-related breathing
disorders (Ali, Pitson, & Stradling, 1996; Gozal, 1998). Furthermore, research has demonstrated
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that parent report of daytime sleepiness and hyperactivity can develop, though to a lesser extent,
in children who habitually snore but do not have meet criteria for a sleep-related breathing
disorder (O’Brien et al., 2004; Beebe, 2006; Montgomery-Downs et al., 2003). This finding has
implications for a detailed screening of sleep-related difficulties for all pediatric populations, but
particularly for those already at increased risk for EF dysfunction and sleep difficulties, such as
children with NF1. Given the evidence that behavior and learning improve after effective
treatment of sleep-related breathing disorders (Montgomery-Downs, Crabtree, & Gozal, 2005;
Chervin et al., 2006), early screening and treatment of sleep difficulties will benefit multiple
facets of functioning.

The results of the current study also highlight the importance of a comprehensive, multimethod assessment of EF for children with NF1. While assessment of EF is routine in
neuropsychological evaluations, clinicians are likely to differ in their method of determining the
integrity of EF skills. The present study is in line with previous research highlighting the need
for EF to be considered a diverse and distinguishable, yet interconnected set of processes that
underlie goal-directed behavior, rather than a single unitary construct. In addition to this crucial
consideration, it is also important that clinicians be explicit about their interpretation of various
EF processes, and steer away from generalizing deficits with one EF process to another.
Incorrect categorization or descriptions of a child’s EF performance may lead to an inaccurate
depiction of a child’s neuropsychological profile and may hinder access to and/or responses to
appropriate interventions.
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Limitations and Future Directions
While the present study provides clinically relevant information about the pattern of EF
across performance-based and functional parent-reported EF measures, and identifies
contributing factors to executive dysfunction in children with NF1, there are limitations in the
study design that will be useful to address in future research. First, this study utilized a relatively
small sample size that may have limited our ability to identify significant results. Future studies
employing larger sample sizes would improve power and generalizability of results. Second, this
study used published normative data as a comparison when examining EF across performancebased and parent-reported functional measures. Future research that utilizes a control group of
unaffected children and a comparison group of children with ADHD (without NF1) from the
community would help control for this limitation. Third, an additional limitation is that it utilized
the BRIEF, in which there is currently an updated version available for administration (BRIEF-2;
Gioia et al., 2015). While no new items were added to the clinical scales in the recent version of
the measure, the BRIEF-2 has fewer items, a new index (Emotion Regulation Index), and rearrangement of scale content occurred resulting in the creation of two scales (Self-Monitor and
Task-Monitor) out of the BRIEF Monitor scale items. However, it is expected that the results of
the current investigation translate to use with these updated measures as correlations between the
parent-reported BRIEF and BRIEF-2 have been found to be generally high, with most
coefficients greater than .80 (BRIEF-2; Gioia et al., 2015). However, as expected given the
changes made between editions, the original BRIEF Monitor scale and the BRIEF-2 Task
Monitor scale had lower coefficients (r = .69). Future projects utilizing parent-reported BRIEF
data may benefit from re-scoring the data using BRIEF-2 scoring. Fourth, although it has clearly
been elucidated that EF cannot be understood as constituting a single entity, and rather must be
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considered as several different processes, the present study did not comprehensively examine all
EF constructs. The most notable absence from our performance-based EF measures was a task
assessing planning, problem-solving, and organization. Ideally, future research should include a
comprehensive research battery that is exhaustive in its multi-method efforts for EF tasks that
includes a task of planning, problem-solving, and organization.
Finally, while the current study utilized a multi-method approach using performancebased and functional EF measures to simultaneously examine EF, for psychosocial functioning
and sleep-related difficulties, our investigation relied solely on parent report. Relying exclusively
on parent report may introduce response bias for these constructs and does not provide insight
into the child’s own perception of these areas of functioning. It is important to note that method
variance may play a role in the observed relations between functional EF and other parentreported measures. For psychosocial functioning in particular, prior research has suggested that
parent-child agreement in reporting of behavior is quite low, with correlations as low as 0.25 for
some behaviors (Achenbach, McConaughy, & Howell, 1987). Low agreement has been found to
be particularly evident when rating behaviors that are not observable, such as internalizing
problems (March et al., 1997; Rey, Schrader, & Morris-Yates, 1992). Future research examining
internalizing problems in school-aged children with NF1 would benefit from inclusion of a selfreport measure of depression and anxiety. The current study also relied on parent report for
assessing sleep characteristics. While the PSQ has been validated against polysomnography, it
has been found that sleep diary estimates, actigraphy estimates, and total sleep times differed
substantially in a study examining sleep in adolescents (Short et al., 2012). Future studies in
which actigraphy measurements are collected in conjunction with parent reported data will
enable a more comprehensive assessment of the presence of sleep-related difficulties in children
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with NF1, and its contribution to overall functioning. In addition, while we examined EF from
both a performance-based and functional parent-reported perspective, future studies would
benefit from including teacher report when sampling EF difficulties in children with NF1. In
some ways, teachers may be more reliable reporters of day-to-day functional EF due to the
higher demand for EF skills in the school setting rather than home. This may be especially true
for younger, preschool-aged children. Furthermore, given the very nature of their work, teachers
may also be more reliable reporters compared to parents given they often have a better sense of
age-typical behavior. Future research utilizing a multi-informant approach that includes teacher
report would be useful in characterizing EF difficulties in different contexts and environments.
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Table 1. Evidence for executive functioning impairments in children with NF1
Area of Impairment
Inhibition

Supporting Studies using
Performance-based Measures
Ferner et al. (1996)

Supporting Studies using
Functional Measures
Payne et al. (2011)

Rowbotham et al. (2009)

Supporting Studies using
Performance-based and Functional Measures
Mautner et al. (2002)
Plasschaert et al. (2015)

Huijbregts et al. (2010)
Gilboa et al. (2011)
Isenberg et al. (2013)
Pride et al. (2017)
Lion-Francois et al. (2017)
Mazzocco et al. (1995)
Casnar & Klein-Tasman (2017)
Working Memory

Huijbregts et al. (2010)

Payne et al. (2011)

Ulrich et al. (2010)

Rowbotham et al. (2009)

Sangster et al. (2011)

Gilboa et al. (2014)
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Ferner et al. (1996)

Casnar & Klein-Tasman (2016)

Payne et al. (2012)

Plasschaert et al. (2015)

Champion et al. (2014)
Cognitive Flexibility/Shifting

Hofman et al. (1994)

Payne et al. (2011)

Descheemaeker et al. (2005)

Pride et al. (2010)

Plasschaert et al. (2015)

Rowbotham et al. (2009)
Roy et al. (2014)
Lion-Francois et al. (2017)
Casnar & Klein-Tasman (2016)
Planning/Organization

Hofman et al. (1994)
Hyman et al. (2005)
Pride et al. (2010)
Roy et al. (2010)
Galasso et al. (2014)

Payne et al. (2011)

Gilboa et al. (2014)
Plasschaert et al. (2015)

Table 2. Summary of measures for current study
Construct
Executive Functioning

Measure

Measure Type

Working Memory

NIH Toolbox List Sorting Working Memory (Toolbox LSWM)

Performance-based; Dimensional

Cognitive Flexibility/Shifting

NIH Toolbox Dimensional Change Card Sort (Toolbox DCCS)

Performance-based; Dimensional

Inhibition

NIH Toolbox Flanker Inhibitory Control and Attention (Toolbox Flanker)

Performance-based; Dimensional

Working Memory

Cogstate One Back Test (Cogstate OBT)

Performance-based; Dimensional

Inhibition

NEPSY-II Response Set (NEPSY-II RS)

Performance-based; Dimensional

Working Memory

DAS-II Recall of Sequential Order; Recall of Digits Backward (RSO;
RDB)

Performance-based; Dimensional

Behavior Rating Inventory of Executive Function (BRIEF)- Parent

Parent-reported; Dimensional

Visual Attention

Cogstate Identification (Cogstate ID)

Performance-based; Dimensional

Visual Attention
Auditory Attention

NIH Toolbox Flanker Inhibitory Control and Attention (Toolbox Flanker)
NEPSY-II Auditory Attention/Response Set (NEPSY AA)
Kiddie Schedule for Affective Disorders and Schizophrenia (KSADS)ADHD Section

Performance-based; Dimensional
Performance-based; Dimensional
Parent-reported; Examiner-rated;
Categorical

ADHD symptomatology

Conners Short Form (Conners)- Parent

Parent-reported; Dimensional

Total Parental SES

Hollingshead Four-Factor Index of Socioeconomic Status (Hollingshead)

Parent-reported; Examiner-rated;
Dimensional

Anxiety symptomatology

Spence Children’s Anxiety Scale (SCAS)

Parent-reported; Dimensional

Behavior Assessment System for Children, Second Edition (BASC-2)

Parent-reported; Dimensional

Pediatric Sleep Questionnaire (PSQ SRBD)

Parent-reported; Categorical

Pediatric Sleep Questionnaire (PSQ)

Parent-reported; Categorical

Differential Ability Scales, Second Edition (DAS-II GCA)

Performance-based; Dimensional

Inhibition, Working Memory, Cognitive
Flexibility/Shifting, Planning/Organization
ADHD Symptomaology
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ADHD symptomatology

SES

Anxiety
Depression
Depression symptomatology
Sleep
Sleep-Related Breathing Disorder
Sleep-related problems
Overall Cognitive Functioning
General Conceptual Ability (GCA)
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Table 3. Participant Demographic Data (n = 40)
Variable
Score/Percent
Mean Age (SD)
10.91 (1.57)
Sex (%)
Males
22 (55)
Females
18 (45)
Ethnicity (%)
Caucasian
33 (83)
African American
4 (10)
Asian
1 (2)
Biracial
2 (5)
Mean SES Index (SD)
41.22 (12.95)
Maternal Education (%)
HS Diploma
7 (17)
Some College
11(28)
College Degree
8 (20)
Grad/Prof College
14 (35)
Mean GCA (SD)
93.90 (13.24)
Current Grade (SD)
4.93 (1.64)
Special Education Services (%)
Yes
21 (53)
No
19 (47)
Comorbid Diagnoses (%)
None
21 (52.5)
ADHD
15 (37.5)
Inattentive type
8 (20)
Hyperactive/Impulsive type
3 (7.5)
Combined type
4 (10)
Generalized Anxiety Disorder
1 (2.5)
MD, Language Disorder
1 (2.5)
RD, Language Disorder
1 (2.5)
MD, RD, Language Disorder
1 (2.5)

NF1 Diagnosis (%)
Sporadic
Familial

27 (68)
13 (32)
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Table 4: BRIEF Parent Descriptive Statistics and Differences from Normative Mean (One-sample t-tests)
Domain/Index
N
M (SD)
t
p
≥ 1 SD above mean
Inhibit
40
56.70 (10.76)
3.94
<.001
13 / 40 32.5%)
Shift
40
53.33 (13.48)
1.56
.127
10 / 40 (25%)
Emotional Control
40
52.75 (10.36)
1.68
.101
10 / 40 (25%)
BRI
40
55.15 (10.45)
3.12
.003
12 / 40 (30%)
Initiate
40
57.08 (9.15)
4.89
<.001
15 / 40 (37.5%)
Working Memory
40
58.98 (10.43)
5.44
<.001
15 / 40 (37.5%)
Plan/Organize
40
57.18 (9.98)
4.54
<.001
17 / 40 (42.5%)
Organization of Materials
40
58.23 (9.66)
5.38
<.001
20 / 40 (50%)
Monitor
40
59.55 (10.74)
5.62
<.001
18 / 40 (45%)
MI
40
59.10 (9.58)
6.00
<.001
18 / 40 (45%)
GEC
40
59.13 (10.58)
5.45
<.001
18 / 40 (45%)
Note: Higher BRIEF mean scores reflect more difficulty
BRI= Behavioral Regulation Index; MI=Metacognition Index, GEC= Global Executive Composite
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Table 5. EF/Attention Performance Descriptive Statistics and Differences from Normative Mean (One-sample t-tests)
Measure/Subtest
N
M (SD)
t
p
≥ 1 SD below mean
DAS-II RSO
40
45.88 (7.25)
-3.59
.001
9 / 40 (22.5%)
DAS-II RDB
40
43.25 (8.23)
-5.18
<.001
9 / 40 (22.5)
Toolbox DCCS
37
94.14 (12.05) -2.96
.005
8 / 37 (21.6%)
Toolbox LSWM
37
98.51 (14.04) -0.64
.524
7 / 37 (18.9%)
Toolbox Flanker
36
87.99 (13.11) -5.49
<.001
18 / 37 (48.6%)
Cogstate Identification
39
-.07 (1.02)
-.431
.669
11 / 39 (28.2%)
Cogstate OBT Speed
39
.47(.97)
3.01
.005
3 / 39 (7%)
Cogstate OBT Accuracy
39
.05 (1.00)
.315
.755
4 / 39 (10.2%)
NEPSY-II AA
40
9.13 (3.38)
-1.64
.110
12 / 40 (30%)
NEPSY-II RS
40
8.70 (3.47)
-2.37
.023
15 / 40 (37.5%)
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Table 6. Relations between Performance EF/Attention Measures and Functional EF
BRIEF BRIEF BRIEF BRIEF BRIEF BRIEF BRIEF BRIEF BRIEF BRIEF
Inhibit Shift
EC
BRI Initiate WM Plan/Org Org/Mat Monitor
MI
DAS-II RSO
-.037 -.007 -.245 -.110 -.086 -.151
-.154
.013
-.184
-.211
DAS-II DB
-.102 .109
.094 -.012 .144 -.047
-.004
.138
-.065
-.017
Toolbox DCCS
-.354 -.198 -.097 -.290 -.328 -.325
-.162
-.226 -.519*
-.243
Toolbox LSWM
.002 -.159 -.125 -.108 -.131 -.149
-.157
-.159
-.236
-.235
Toolbox Flanker
.093 -.037 .137
.097
.069
.028
.136
.066
.071
.063
Cogstate Identification
.060
.132
.079
.157 -.066 .053
.000
-.012
-.027
.000
Cogstate OBT Speed
-.229 -.120 -.222 -.176 -.176 -.140
-.043
.024
-.238
-.050
Cogstate OBT Accuracy .016 -.039 .020 -.075 -.236 -.296
-.264
-.250
-.226
-.220
NEPSY-II AA
-.008 .190
.022
.075
.111 -.126
.012
-.085
-.020
-.104
NEPSY-II RS
-.398 .004 -.193 -.290 -.278 -.319
-.092
-.025
-.391
-.235

BRIEF
GEC
-.074
.048
-.286
-.120
.025
.102
-.057
-.171
-.032
-.295

Note: * p < .05; ** p < .01; significant difference determined based on q-value (FDR derived significance threshold)
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EC= Emotional Control; BRI= Behavioral Regulation Index; WM= Working Memory; Plan/Org=Plan/Organize; OrgMat=Organization of Materials;
MI=Metacognition Index, GEC= Global Executive Composite

Table 7. Descriptive Statistics and Group Differences on Performance EF/Attention Measures
NF1
NF1 + ADHD
Measure
N
Mean (SD)
N
Mean (SD)
F
q-value
DAS-II RSO
25
47.12
6.73
15 43.80
7.83
1.81
.689
DAS-II DB
25
43.68
8.32
15 42.53
8.32
0.29
.746
Toolbox DCCS
23
95.96
12.92
14 91.14
10.24
0.96
.739
Toolbox LSWM
23 101.04 12.90
14 94.36
15.31
1.94
.689
Toolbox Flanker
22
88.90
14.07
14 86.57
11.81
0.26
.746
Costate ID
25
-0.13
1.13
14
0.03
0.81
0.0
.991
Cogstate OBT Speed
25
0.66
1.04
14
0.13
0.74
3.05
.677
Cogstate OBT Accuracy
25
0.04
0.88
14
0.07
1.21
0.06
.888
NEPSY-II AA
25
9.32
2.96
15
8.80
4.07
0.45
.739
NEPSY-II RS
25
9.20
3.23
15
7.87
3.82
0.62
.734

D
.46
.18
.34
.47
.17
.00
.59
.08
.23
.27
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Table 8. BRIEF Descriptive Statistics and Group Differences based on ADHD
NF1
NF1 + ADHD
Measure
N
Mean
(SD)
N
Mean
(SD)
Inhibit
25
51.28
6.68
15 65.73
10.29
Shift
25
50.24
12.96
15 58.47
13.16
Emotional Control
25
49.60
8.69
15 58.00
11.03
BRI
25
50.64
7.79
15 62.67
10.17
Initiate
25
54.88
8.95
15 60.73
8.53
Working Memory
25
55.16
8.43
15 65.33
10.57
Plan/Organize
25
53.00
8.74
15 64.13
7.99
Organization of Materials 25
56.44
10.54
15 61.20
7.38
Monitor
25
54.08
7.60
15 68.67
8.94

F
29.12
3.73
7.13
17.74
4.15
11.26
16.17
2.35
30.23

q-value
.000
.067
.015
.000
.058
.003
.000
.133
.000

D
1.76
.63
.87
1.37
.66
1.09
1.31
.50
1.79

MI
GEC

20.48
13.66

.000
.002

1.48
1.21

25
25

54.76
54.96

7.90
9.58

15
15

66.33
66.07

7.69
8.49

Note: Higher BRIEF mean scores reflect more difficulty
BRI= Behavioral Regulation Index; MI=Metacognition Index, GEC= Global Executive Composite

Table 9. BRIEF Descriptive Statistics and Group Differences for based on Sleep-related Breathing Disorder
NF1
NF1 + SRBD
Measure
N
Mean
(SD)
N
Mean
(SD)
F
q-value
D
Inhibit
26
53.28
8.46
14 63.14
11.85
9.38
.014
1.0
Shift
26
52.85
14.90
14 54.21
10.82
.091
.764
.10
Emotional Control
26
51.73
10.45
14 54.64
10.29
.714
.443
.28
BRI
26
53.19
10.16
14 58.79
10.35
2.72
.166
.55
Initiate
26
55.42
8.74
14 60.14
9.40
2.52
.166
.53
Working Memory
26
56.08
9.42
14 64.36
10.37
6.55
.015
.85
Plan/Organize
26
54.69
9.05
14 61.79
10.32
5.06
.066
.75
Organization of Materials 26
57.15
10.24
14 60.21
8.47
.911
.422
.32
Monitor
26
55.42
8.50
14 67.21
10.48
14.85
.000
1.3
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MI
GEC

26
26

56.00
56.69

8.51
10.44

14
14

64.86
63.64

9.04
9.65

Note: Higher BRIEF mean scores reflect more difficulty
BRI= Behavioral Regulation Index; MI=Metacognition Index, GEC= Global Executive Composite

9.45
4.24

.014
.084

1.0
.68

Table 10. Regression Analyses: Contributions to Functional and Performance EF
Functional Parent-Reported EF
(BRIEF GEC)

Model
DAS-II GCA
SES
ADHD Diagnosis
SRBD Criteria
SCAS Total Anxiety
BASC-2 Depression scale

F

df

p

R2

5.51

6, 33

.001
.805
.536
.034
.067
.284
.009

.500

p
.273
.023
.328
.701
.729
.788
.482

R2
.217

β

.031
.078
.312
.273
.153
.408

Performance-Based Inhibition
(NIH Toolbox Flanker)

64
Model
DAS-II GCA
SES
ADHD Diagnosis
SRBD Criteria
SCAS Total Anxiety
BASC-2 Depression scale

F
1.34

df
6, 29

GEC= Global Executive Composite; GCA = General Conceptual Ability

β
.401
.166
-.073
-.067
.051
-.139

Figure 1. Parent-reported level of difficulties on the BRIEF
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BRI = Behavioral Regulation Index; MI= Metacognition Index; GEC = Global Executive Composite.

13
4
23

Organization
of Materials
13
7
20

Monitor

MI

GEC

12
6
22

12
6
22

12
6
22

Figure 2. Level of Difficulties on Performance-based EF Measures
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Figure 3. Group Differences in Parent-Reported EF for children with NF1 with and without ADHD
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Figure 4. Group Differences in Parent-Reported EF for children with NF1 with and without Sleep-related Breathing Disorder
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Symposium, San Diego, CA.
Potegal, M., Yund, B., Shapiro, E. (2011, February). Comparison of Social/Emotional Function in Children with
MPS I and MPS III: Interim Report. Poster presented at the Lysosomal Disease Network’s WORLD
Symposium, Las Vegas, NV.

________________________________________________________________________________

PRESENTATIONS AT LOCAL/REGIONAL MEETINGS & CONFERENCES
French, S., Rivera, K., Yund, B., Klein-Tasman, B. Behavioral Play Therapy with Children with Williams
Syndrome: Examination of Parent Ratings of Anxiety. (2019, April). Poster presented at UWM
Undergraduate Research Symposium, Milwaukee, WI.
Corrigan, E., Yund, B., Lee, K., & Klein-Tasman, B.P. (2017, April). Longitudinal Examination of Anxiety
Levels in Children with Neurofibromatosis type 1. Poster presented at UWM Undergraduate Research
Symposium, Milwaukee, WI.
Corrigan, E., Bielunski, G., Stemper, B., Lee, K., Yund, B., Casnar, C., & Klein-Tasman, B.P. (2016, April).
Examination of Anxiety Levels in Children with Neurofibromatosis type 1. Poster presented at UWM
Undergraduate Research Symposium, Milwaukee, WI.

________________________________________________________________________________

TEACHING EXPERIENCE
Fall 2018

Guest Lecturer: Psych 912 Developmental Psychopathology (Graduate Level)
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University of Wisconsin – Milwaukee, Department of Psychology
Topic: Autism Spectrum Disorder and Intellectual Disability
Fall 2018

Guest Lecturer: Psych 802 First Year Clinical Practicum (Graduate Level)
University of Wisconsin – Milwaukee, Department of Psychology
Topic: Clinical Use of the Wechsler Individual Achievement Test – Third Edition

Fall 2018

Teaching Assistant: Psych 821: Second Year Clinical Practicum
University of Wisconsin – Milwaukee, Department of Psychology
Supervisors: Kristin Smith, Ph.D., Han-Joo Lee, Ph.D.; Bonnie Klein-Tasman, Ph.D.

2016 – 2017

Teaching Assistant: Psych 802/821 First and Second Year Clinical Practicum
University of Wisconsin – Milwaukee, Department of Psychology
Supervisors: Kristin Smith, Ph.D.; Han-Joo Lee, Ph.D.

2015 – 2016

Teaching Assistant: Psych 802 First Year Clinical Practicum
University of Wisconsin – Milwaukee, Department of Psychology
Supervisors: Kristin Smith, Ph.D.; Han-Joo Lee, Ph.D.

Fall 2014

Teaching Assistant: Psych 260 Child Psychology
University of Wisconsin – Milwaukee, Department of Psychology
Instructor: Kristin Smith, Ph.D.

________________________________________________________________________________

PROFESSIONAL MEMBERSHIPS
2018 – present
2018 – present
2016 – present
2016 – present
2014 – present

Association for Psychological Science, Student Affiliate
APA, Division 40 (Clinical Neuropsychology), Student Affiliate
American Psychological Association, Student Affiliate
International Neuropsychological Society
UWM Association of Graduate Students in Neuropsychology

________________________________________________________________________________

SEMINARS, SPECIALIZED TRAINING, and CERTIFICATIONS
2017 – 2019

Neuropsychology Journal Club
Medical College of Wisconsin, Milwaukee, WI
Weekly journal club involving discussion of clinical neuropsychology research.

2017 – 2019

Neuropsychology Seminar
Medical College of Wisconsin, Milwaukee, WI
Weekly didactic seminar involving broad topics related to clinical neuropsychology.

2017 – 2018

Cases in Clinical Neuropsychology
University of Wisconsin-Milwaukee
Faculty Supervisor: Krista Lisdahl, Ph.D.
Graduate seminar involving fact finding sessions and broad topics related to clinical
neuropsychology.

Fall 2016

Evidence-Based Practice for Treatment of Eating Disorders
University of Wisconsin – Milwaukee, Milwaukee, WI
Lecturer: Stacey Nye, Ph.D., FAED
Graduate seminar in etiology, assessment, and diagnosis of DSM-5 feeding and eating
disorders, the physiological, metabolic, and medical complications related to malnutrition,
issues and controversies involved with weight stigma and dieting, ethical issues clinicians
face in context of treatment, and basic principles of an integrative treatment approach
with an eating disordered population.
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Spring 2016

Behavioral Activation for Depression
University of Wisconsin – Milwaukee, Milwaukee, WI
Lecturer: Christopher Martell, Ph.D.
Graduate seminar in basic theory, principles, and practice of utilizing behavioral
activation in the treatment of depressive disorder. Instruction in the development of
activity scheduling, functional analysis, behavioral experiments, and combating
rumination with cognitive strategies.

Fall 2016

ADOS-2 Research Reliability (Modules 3 & 4)

Fall 2015

ADOS-2 Clinical Training
University of Wisconsin – Madison, Madison, WI
Wisconsin LEND Training Program
Seminar training in the development, psychometric properties, administration, scoring,
and operationalizing diagnostic criteria for ASD using the ADOS-2.

________________________________________________________________________________

HONORS and AWARDS
2019
2018
2018
2017
2016
2016
2016
2015
2009 – 2010

UWM Association of Graduate Students in Neuropsychology Travel Award
UWM Graduate Student Travel Award
UWM Association of Graduate Students in Neuropsychology Travel Award
UWM Graduate Student Travel Award
David Zeaman Graduate Student Award, Gatlinburg Conference
UWM Graduate Student Travel Award
UWM Association of Graduate Students in Neuropsychology Travel Award
UWM Department of Psychology Summer Fellowship
Dean’s List, University of Minnesota-Twin Cities

________________________________________________________________________________
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